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Abstract
Biofilms are a survival mechanism commonly employed by communities of bacteria for
adherence and protection. Bacteria produce a matrix of polymers (e.g. exopolysaccharides, such
as cellulose) that allow them to exert control on their local environment. In the case of cellulose
biofilms, acetylation (addition of acetate on carbohydrates) is paramount for polymer integrity
and in some cases virulence. For this research, the wrinkly spreader (WS) genotype of the
emergent human pathogen Achromobacter insuavis facilitates infections of the eyes of contact
lens wearers and the lungs of Cystic Fibrosis patients (CF). Chronic infections have created a
growing concern for the protective role biofilms play in antimicrobial resistance. Cellulose
biofilms are an important mechanism for other pathogenic bacteria such as Pseudomonas
fluorescens, which affect produce and water sources by forming a robust cellulose-containing
biofilm that enhances the ability of the bacteria to spread across surfaces. Both A. insuavis and P.
fluorescens contain the wssF gene that encodes a putative O-acetyltransferase protein, in that
site-specific mutagenesis of wssF resulted in non-acetylated cellulose. The purpose of this
research was to characterize WssF from both species, to understand its role in the production of
acetylated cellulose and investigate its role as a putative O-acetyltransferase protein. This
research progressed successfully through three primary objectives; expression and purification of
WssF, functional characterization of acetyltransferase activity and structural characterization of
the WssF protein. Esterase activity, the first step in acetyl transfer, was successfully
characterized through a kinetic workup, which found KM (2.88 – 7.18 mM), kcat (0.24 – 0.34 s-1)
and, Vmax (47 – 83 s-1*M-1) values comparable to homologous acetyltransferases. Following this,
acetyl transfer was confirmed through the use of Thin Layer Chromatography (TLC) and Mass
Spectrometry, both mono and diacetylated cellopentaose was produced in the presence of
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unmutated WssF. Site Directed Mutagenesis (SDM) of the predicted catalytic triad residues (Ser,
Asp and, His) resulted in up to 85% inhibition of esterase activity and at least 95% of acetyl
transfer thereby confirming their role in catalysis. Successful functional characterization of WssF
has allowed for screening of potential enzyme inhibitors by High Throughput Screening (HTS)
assays. A set of 18 compounds has been selected for further study as potential WssF
acetyltransferase inhibitors. Finally, structural characterization of WssF has been advanced, with
optimal conditions for crystallization having been determined and (~2Å) data sets collected but
solving a structural model of WssF is ongoing. The findings of this research successfully outline
the functional and structural characteristics of WssF, which are the first for a cellulose
acetyltransferase involved in biofilm formation. This thesis further develops our understanding
of biofilm modification, a vital step in combating antimicrobial resistance.
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1.Introduction
1.1 Biofilms
A common survival strategy for many bacteria is the biosynthesis and export of
polysaccharides to immobilize the cells within a protective biofilm together with fragments of
DNA and peptides. Biofilms are a complex matrix of synthesized exopolymers utilized for
adherence to various surfaces (1). A growing body of literature underscores the importance of
further research into biofilms. For example, the Center for Disease Control (CDC) estimates 48
million Americans suffer annually from foodborne illnesses (many caused by biofilm-forming
bacteria) costing between $50-70 billion per annum (2). Unofficial estimated costs of biofilm
infections, not including foodborne illness, was $94 billion in the USA alone, with an additional
$105 billion spent on dental care in 2007 (3–5). In the healthcare setting nosocomial, or hospital
acquired, infections frequently arise due to patients being exposed to hard-to-clean equipment
ranging from catheters to ventilators that harbour biofilms (3, 6). The costs associated with
treating these biofilm-related infections have created a large need for further research into
biofilm forming pathogens.
Even outside of the clinical healthcare setting personal hygiene and comfort are affected
by biofilm forming bacteria. Cultures grown from the contact lenses of Corneal Infiltrative Event
(CIE) patients showed 61 % of the cases had Acromobacter spp. present (7). All the contact len
cases examined used multipurpose disinfecting solutions (MPDS), which are tested for a
reduction in P. aeruginosa, S. marcescens and S. aureus growth (8). These MPDS are not tested
against a multitude of other bacteria, such as, the various Achromobacter spp. As a result of the
inability of many MPDSs to fully sterilize the contact lens cases CIEs, such as, in Figure 1.1,
occur after prolonged usage (7). In response to increased bacterial load, the typically avascular
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cornea will have white blood cells migrate into the area to form white plaques (9). In severe
cases, infectious events may threaten to destroy eyesight completely. The incidence for adverse
effects, such as, CIE or keratitis are estimated to range from approximately 40 in 100,000 users
up to 25 in 10,000 for individuals who wear the contact lens for longer than 10-12 hours and/or
greater than 5 days a week (7, 10, 11). Due to the lack of efficacious treatments infections by
Achromobacter spp. remain a prominent risk for all contact lens wearers. Therefore, treating the
contact lenses more effectively will provide not only health benefits but also increase
convenience for the average contact lens wearer.

Figure 1.1 Presence of CIEs after extended contact lens case use with MPDS as only cleaning agent.
Multipurpose disinfecting solutions have been found to be inadequate in preventing CIEs without also
replacing contact lens cases at regular intervals. (Adapted from Kilvington et al. (7))

Preventing negative healthcare outcomes is one of the benefits of maintaining the quality
of any society’s food and water supplies. Unfortunately, our food and water supply chains are
susceptible to contamination biofilm forming bacteria. The adverse effects of biofilm forming
bacteria are not only related to health, but also strongly connected to economic outcomes. For
example, the production of biofilms by Pseudomonas within raw milk allow for bacteria
communities to survive the pasteurization process (12). Even biofilms of nonpathogenic bacteria
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present within food processing facilities have recently been identified as overlooked sources of
contamination that might potentially harbour pathogenic bacteria (13). Allowing this bacterial
presence within treated milk reduces the shelf life of the final products and reduces the quality of
products that companies sell. The damaging effects of biofilm production on agriculture are not
limited to the dairy industry. Pseudomonas spp. have also caused an epidemic of the kiwi canker,
which has threatened kiwi crops worldwide (14–16). Repercussions from the loss of the kiwi will
have international economic effects, as kiwis are a main export of many Pacific countries. This
loss will not just be economic as kiwi fruits are also a major cultural export of some countries,
like New Zealand. The impact of not being able to stop these infections ranges from agricultural
sustainability, and economic loss to the diminishing of cultural/national identity.
While most of the focus on biofilms has revealed the negative impacts of formation,
there are emerging cases where biofilm formation could be productive. In North America the
presence of some Pseudomonas spp. have been found to protect crops of tomatoes and radishes
from wilting (17, 18). As cash crops, tomatoes and radishes not only provide food security but
also economic stability for vast communities (19, 20). The cause of wilting is due to a fungus
called Fusarium; fortunately multi-species communities, including Achromobacter and
Psuedomonas, outcompete the fungus for iron within the soil; thereby making it inhospitable for
further infestation (17, 18). Biofilms allow the bacteria to resist the physical forces, such as,
rainwater, which in turn allows the bacteria to survive longer on the crops as they combat the
fungal infestation. In these cases, the ability of the biofilm to protect the symbiotic bacteria is an
asset for economic gain instead of an adverse health effect. Thus, there are potential benefits to
learning not just how to disrupt biofilms, but how to manipulate certain community members to
thrive within a desired environment.
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1.2 Benefits of Biofilm Production
Adaptation for increased survival, through the production of a protective extracellular
polymeric substance (EPS) barrier, is common in environments ill-suited for “free living”
(planktonic) lifestyles (21, 22). Consequently, biofilms (composed of EPS) are produced by
many different species of bacteria living as a community for protection (23, 24). Multispecies
biofilms allow each species to perform specialized tasks a homogenous microbial community
may not be able to, allowing the multispecies biofilm improved utilization all the potential
metabolites within their environment (25). In the case of Inflammatory Bowel Disease (IBD) the
intestinal microbiota changes significantly, producing larger biofilms, with increased affinity for
iron abundance (25). While these changes negatively affect the hosts overall health, the bacteria
have an increase in viability. More specifically in the case of Crohns disease, inflammation due
to an abnormal immune response decreases the functionality of the intestines without eradicating
the underlying infection (25, 26). Reducing intestinal efficiency increases the nutrients available
for the pathogenic bacteria, while simultaneously reducing the viability of symbiotic gut
microflora. Bacteria within the biofilm form controlled extracellular environments, which allow
them to share DNA and metabolites. These systems become even more complicated as gradients
of nutrients, waste, chemical signals, toxins, antibiotic chemicals, etc. form. Shared metabolite
utilization, however, is not the only benefit as biofilms also increase bacterial adhesion to solid
surfaces (27, 28). Enhanced adhesion is extremely valuable to bacteria that occupy irrigation
systems or the digestive tract where supplied nutrients flow through the system from a single
source. The ability to remain attached to a location with a constant nutrient source avoids
excretion, while increasing exposure to metabolites, increasing fitness and viability. Enhanced
adhesion avoids excretion as it allows the bacteria to remain on crops and storage containers
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when experiencing shearing forces (e.g. rain or cleaning cycle) (29). Thus, the benefit of EPS
production (inherent in biofilms) is not only protection, but increased control over the external
environment of the bacteria.
Biofilms are able to protect microbial communities from both host immune functions and
antibiotic treatments. By producing a barrier, the multitude of antibodies and neutrophils
produced by a host are unable to interact with, identify or remove the bacterial presence (30). In
some cases, the biofilm communities are mostly non-pathogenic bacteria, like those that form the
gut microbiota. A problem arises when pathogenic bacteria join these non-pathogenic
communities, like in the case of IBD as previously discussed (25). The once commensal
community of bacteria breaks the tenuous balance with the host and its immune system relying
on the biofilm community for survival. Biofilms offer embedded bacteria more than just
protection from the immune system. Embedded bacteria also benefit from antibiotic resistance,
which is increasingly being recognized as an urgent problem that threatens to make current
medications obsolete (31, 32). When antimicrobials are introduced to a biofilm community a
concentration gradient is formed as they slowly diffuse through the biofilm matrix, which
generates lower antibiotic dosages among the less metabolically active bacteria, therefore
allowing potentially sensitive cells to survive (33). These lower antibiotic dosages are less
effective allowing resistant bacteria the opportunity to transfer plasmids, containing resistance
genes, to neighboring bacteria that would otherwise be susceptible (3). New approaches to
increase antibiotic efficacy and/or generate new antibiotics are crucial to our ability to control
these bacterial communities (34). In summary, once the biofilm matrix surrounds the cell it
offers protection from antibiotics, competing organisms, harsh environmental factors, and host
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immune systems (3, 33). This complex defense mechanism has created an urgent need for
research into remediating the biofilm barrier (3).
1.3 Biofilm Composition and Development
A biofilm is a complex matrix comprised primarily by EPS that can be produced by
either a homogenous or heterogenous community of bacteria (1, 30). Microcolonies
characterized by their EPS make up neighborhoods, which build the foundations that determine
the structural formation of the maturing biofilm later in development (30, 35). Each microcolony
may form a different EPS or proliferate in a way that changes their neighborhoods structural
foundation (35, 36). While the EPS provides the majority of the structure and strength found
within a biofilm, the composition is far from homogenous as seen in Figure 1.2. Biofilms are
diverse mixture comprised of lipids, nucleic acids, proteins and, carbohydrates, which are the
most abundant substance within the matrix (36, 37).
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Figure 1.2 The composition of a developing biofilm (Adapted from (38)). On the left (A) is a
representation of the complex environment produced by biofilm forming bacteria. The EPS produced
forms a protective barrier reducing the effects of toxins, lytic phages and, protozoa. An environment of
various proteins, eDNA, fatty acids and nutrients forms allowing the cells to create a shared extracellular
metabolism. The production of nutrient, waste and chemical signal gradients also form as a result of the
thick EPS, which force the cells to adapt. On the right (B) is a figure representing dispersion of a mature
biofilm. After/during maturation portions of the biofilm begin to hollow out where cells revert to
planktonic lifestyles. Dispersing cells leave behind the dead cells trapped within the matrix.

Production of a biofilm begins when the bacteria detect sufficient bacterial density within
an environment suitable for formation. This detection is mediated through Quorum sensing,
where chemical signaling molecules allow bacteria to communicate information like population
density (39, 40). Different species use different pathways to detect environmental conditions and
use these signals to help regulate inter and intra species cooperation (40, 41). Adhesion,
population density, and neighboring biofilm production all signal a change in the cyclic
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diguanylate (c-di-GMP) pathway (42–45). Bacteria deploy their survival mechanisms through
control of cytosolic c-di-GMP levels. An example of this control is when phosphodiesterase
enzymes hydrolyze c-di-GMP deactivating the secondary messenger and upregulating motility
(ie. a mechanism of dispersal as depicted in Figure 1.1) (44, 45). Increased motility is achieved
through the production and activation of cellular structures, such as, flagella, which are used to
propel the cell. In the case that external signals indicate sufficient population density at an
interface, diguanylate cyclases increase the levels of c-di-GMP, which in turn up regulate
proteins contributing to adhesion and biofilm formation (42, 46). Maintaining a balance of c-diGMP production and hydrolysis allows the cell to respond with planktonic (motile) or sessile
(biofilm production) modes of growth (Figure 1.3), depending on what environmental pressures
act upon the cell (43).

Figure 1.3 Diagram illustrating Cyclic di-GMP pathway. (Generated in Microsoft Paint)
Diguanylate cyclase increases c-di-GMP levels while phosphodiesterase hydrolyzes c-di-GMP. The
presence of c-di-GMP increases sessile functions and decreases motile functions.
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Figure 1.4 Stages of Biofilm Development (Modified(38)). Biofilm development proceeds in 5 stages.
1) Planktonic cells within the local environment determine whether conditions are favourable for biofilm
formation. 2) Initial attachment of cells is facilitated through utilization of membrane bound constructs,
such as, flagella or pili. 3) Irreversible attachment through the production of exopolysaccharides, which
provide strength and organization. 4) Maturation of biofilm as the organization of the biofilm allows for
the formation of water channels and stratification of the biofilm. 5) Dispersal of the mature biofilm
through both active and passive dispersal allows for cells to either reattach elsewhere or reenter a
planktonic lifestyle.

Once the bacteria receive a signal that a suitable environment is present, the development
of the biofilm can progress through five subsequent stages (Figure 1.4); Planktonic, Initial
attachment, irreversible attachment, maturation and, dispersal. The first stage in biofilm
development is set in motion by the environmental signals discussed previously. Chemical
signals (e.g. N-acyl homoserine lactones, ion concentrations, etc.) cause upregulation in
transcription of the genes encoding diguanylate cyclases, which increase levels of c-di-GMP,
causing a switch to sessile functions (42, 46). With increased transcription of genes encoding for
adhesion proteins, such as, curli fimbriae, there is a parallel down (-) regulation for motility
proteins, such as, flagellar components (46, 47). This change allows for initial attachment
where anchoring of bacteria to various surfaces (e.g. host cell membrane proteins or nutrient rich
soil/sediment) begins. As more cells attach, potentially from diverse species, the cells divide and
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grow forming microcolonies (48). This density change causes upregulation in the genes
responsible for EPS synthesis, modification and, export (as will be discussed in detail later in
section 1.4), which begins stage three, irreversible attachment. As a major component of the
biofilm matrix, EPS forms around and throughout the microcolonies, beginning to create the
extracellular environment previously discussed within the biofilm (49, 50). This causes the
microcolonies to grow and connect forming the neighborhoods that will later dictate the overall
structure of the greater community (30). The formation and development of the microcolonies in
stage three are drastic as seen in Figure 1.5. Early in biofilm development the cells are sparsely
arranged within the biofilm matrix. As the biofilm grows there are significant increases in cell
and matrix density. Cells become densely packed as the biofilm develops from the stage of
irreversible attachment into stage four maturation.

Figure 1.5 Fluorescence Emission Scanning Electron Microscopy images of Bacillus
thuringiensis. (Modified from (51)) Early biofilm development displaying sparsely packed cells Left.
Mature biofilm development displaying densely packed cells (15 days) Right.

Stage four, biofilm maturation, is marked by copious amounts of EPS and pili but also
the development of community structure. The structure of the growing community changes and
expands based on multiple factors. As previously mentioned, the initial attachment and the early
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formation of microcolonies guides how and where the mature biofilm has formed. A driving
factor of this formation is of course access to nutrients, which not only signals a place for initial
attachment but also the formation of channels. Channels for external resources, such as, water
and nutrients form, allowing the network of neighborhoods access (48, 50). However, within
those neighborhoods access to the external environment is not uniform as deeper cells have
limited access to water or nutrients. This creates cells that are less metabolically active as
previously discussed in section 1.2.
As the biofilm matures some areas within the biofilm begin to enter stage 5, dispersion.
Dispersion occurs when external portions are removed from the community by passive or active
dispersal (52). Passive dispersal is when cells are sheared away from the biofilm, by physical
forces, such as, currents or predator grazing (52, 53). Alternatively, active dispersion is an
individual or coordinated community signaling that cause cells on the periphery of the biofilm to
change back to a planktonic lifestyle leaving the biofilm community. These chemical signals
regulate gene transcription to produce phosphodiesterase enzymes that decrease the levels of cdi-GMP in the cytoplasm, which in turn result in the promotion of transcription/translation of
proteins involved in motile functions (42, 46). Whether actively or passively dispersed, cells may
move back into a planktonic lifestyle or find another location to reattach and undergo the stages
of biofilm formation once more.

1.4 Cellulose
Biofilm production is a complex process requiring various proteins to perform a
multitude of functions. Once bacteria sense a need for biofilm production, one or more operons
begin transcription of the required protein complex. Bacterial cellulose synthase (bcs) produces
cellulose, a β1,4 linked glucose polymer, to aid and protect bacteria, such as, E. coli or
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Salmonella spp. Cellulose synthesis and export is achieved primarily by four proteins, BcsA,B,Z
and,C (54, 55). BcsA polymerizes UDP-glucose into the β 1,4 linked polymer concomitant with
transport into the periplasm through its transmembrane pore region (56–58). Interestingly, the
role of BcsA in polymerization is in some biofilm synthase complexes completed by multiple
proteins instead of one. Within the alginate system, for example, the bacteria utilize two well
described proteins, alg44 and alg8 (59, 60). Having multiple solutions for the task of
polymerization displays the complex nature of EPS production. Moving toward the outer
membrane, the next protein is BcsB, which complexes with BcsA and is believed to guide the
growing cellulose polymer through the periplasm (56–58). BcsZ then acts as an endoglucanase;
cleaving the polymerized cellulose chain for release from the cell (61, 62). The function of BcsC
is yet unknown, however, it is believed to function similar to the analogous AlgE/AlgK complex
that exports alginate across the outer membrane in Pseudomonas spp. (63). This would mean
BcsC contains both the β-barrel porin of AlgE and the tetratricopeptide repeat of AlgK allowing
it to guide cellulose through the periplasm and outer membrane. While the Bcs complex does not
directly acetylate cellulose, recent research has indicated the presence and importance of EPS
modifications in the Wss (cellulose) and Alg (alginate) systems. Although the Bcs system does
not acetylate cellulose it is useful for comparing against other cellulose synthase systems like
Wss for determining function of the various proteins.
In the case of A. insuaivs and P. fluorescens, the wss operon is responsible for the
acetylated cellulose synthase apparatus. Potential functions of the proteins within the wss system
were determined using mutant knockouts (22, 28). Mutant knockouts determined wssB,C,D
and,E (analagous to the bcsA,B,Z and,C genes from other systems) are required for cellulose
synthesis. Once removed, the absence of any one of the genes resulted in a mutant that did not
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produce cellulose when stimulated (28). Although important for the synthesis of cellulose, the
function of WssC is currently uncharacterized but believed to be a hypothetical binding domain
(analogous to BcsB). After polymerization, cellulose is translocated through the periplasm where
modification can occur before exportation. Further knockouts found WssF,G,H and,I are
responsible for acetylation of the cellulose polymer (22). Mutants produced a non-acetylated
cellulose polymer that had a decreased capacity for protecting the bacteria from anti-microbial
forces, such as shearing forces (64). Further importance of polymer modification will be
discussed later in section 1.5. In order to visualize the Bcs and Wss systems Figure 1.6 has been
generated, which includes the well described Alginate system for comparison.

Figure 1.6 Graphic representation of alginate and cellulose biosynthetic apparatus The protein
components are color-coded according to predicted function as follows: purple, MinD homolog; green,
synthase; red, c-di-GMP, bis-(3ʹ-5ʹ)- cyclic dimeric guanosine monophosphate binding domain/protein;
orange, exopolysaccharide-modifying enzyme; blue, tetratricopeptide repeat; yellow, β-barrel porin; and
white, hypothetical binding domain. (Generated in Microsoft Paint based on (65))

23

Another example that has been extensively researched is the synthesis and modification
of alginate biofilms. Even though the present research has focused on WssF, which is part of the
wss operon for cellulose synthesis, the alginate system provides a useful comparison to the less
characterized cellulose system (Figure 1.6) (65). The algD operon contains genes for the 10
proteins that form an alginate biosynthetic apparatus (66–68). Unlike the alginate system, the
Wss system has two MinD homologues WssA and WssJ, which are believed to be involved in
the localization of the cellulose synthase and O-acetylation proteins respectively (28). Additional
proteins are then needed to coordinate c-di-GMP signal detection and polymer synthesis. In the
case of alginate, the inner membrane located Alg44 protein detects the presence of c-di-GMP
and acts as a positive activator of Alg8 to convert molecules of guanosine 5'-diphosphatemannuronic acid into poly-β-D-mannuronic acid (59, 60). In the cellulose system, the activities
of alg44 and alg8 are hypothesized to be contained in one multi-domain protein, denoted WssB
or BcsA depending on the bacteria it was identified in (28). Following synthesis, certain proteins
perform polymer modifications, such as, O-acetylation, epimerization, cleavage, and more. For
example, AlgF,I,J,X act to O-acetylate the polymer, which has been shown to increase the
strength and organization of the final product (69–71). In the cellulose system WssG,H,I,F bear
sequence homology to the alginate proteins, respectively, and are hypothesized to be responsible
for the acetylation of cellulose biofilms (28). The locations for AlgF,I,J were determined, using
alkaline phosphatase (AP) gene fusions and this work supported bioinformatics sorting programs
(72, 73). Amoung all the randomly inserted AP gene fusions the in-frame fusions to the proteins
algF and algJ had Alkaline Phosphatase activity, indicating that both AlgF and AlgJ were
exported to the periplasm. Further, immunoblot analysis demonstrated that AlgF is a soluble
periplasmic protein, while AlgJ is anchored to the inner membrane (73). Alg J was found to have
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seven transmembrane domains, which anchor the protein, followed by a large periplasmic
domain. AlgF,I,J are believed to transfer an acetyl group across the inner membrane where AlgX
and AlgJ acetylate the alginate polymer (69). Analogous proteins in the teichoic acid alanylation
system flip wall teichoic acids (WTA), produced on the undecaprenyl carrier lipid, through the
inner membrane of Gram-positive bacteria (74). Within this system DltD has recently been
described as an O-acyltransferase in the DLT pathway (74). DltD is believed to utilize a Ser-HisAsp catalytic triad. Both AlgX and AlgJ possess a SGNH hydrolase-like domain that contains a
catalytic triad of Ser-His-Asp to acetylate the alginate polymer. SGNH hydrolases are a vast and
diverse super family of esterases and lipases, which have an alpha/beta/alpha structure, where the
middle beta sheet is normally found to be five parallel strands (75). Based on similarities
between the alginate and cellulose systems, WssI and WssF may also serve as acetyltransferases
due to their SGNH hydrolase-like domain.
Following acetylation, the alginate and cellulose systems have additional similarities and
differences. For example, AlgG from the alginate system has been shown to act as a C5mannuronan epimerase (76). That converts alginate from a solely β-D-mannuronic acid to a
polymer that is infrequently spaced with α-L-guluronic acid; thereby altering the viscosity and
polarity of the final product. In the case of the Wss system, cellulose is produced as a
homopolymer and no equivalent protein to AlgG is present. The similarities between the two
systems then converge again with respect to the other proteins in the periplasm and outer
membrane. The alginate polymer is cleaved by AlgL, similar to WssD/BcsZ, allowing for a
controlled release of the polymer (62). Finally exportation of the polymer is achieved by AlgK (a
tetratricopeptide repeat (TPR) containing protein) that binds the polymer guiding it through the
β-barrel porin AlgE (77–79). In the cellulose system, there are also TPR and β-barrel regions, but
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they are contained within a single WssE/BcsC protein (28). Strong similarities between the
alginate and cellulose synthetic pathways allow for some confidence when predicting the
functions of various Wss proteins.
1.5 Polysaccharide Modification
Comprehending the biological relevance of biofilms requires understanding the
importance of polysaccharide modification. Modified polysaccharides are a common mechanism
for protecting the cell. Acetylation is emerging as one important way of modifying the EPS used
by bacteria for protection. The importance of acetylation, however, is far more wide spread than
just modifying biofilms. Briefly, acetylation is known to play an integral role ranging from
mammalian development to providing increased protection from heat and oxidative stress for
many E.coli proteins (80–82). In the case of acetylating exopolysaccharides, O-acetylation of the
cellulose is used to improve biofilm strength and efficacy (28, 83). For bacterial mutants that
form cellulose without O-acetylation the biofilms where observed to be stringy and thinner than
wildtype biofilms (28). Spiers and colleagues (2003) successfully visualized the effects of nonacetylated cellulose as seen in Figure 1.7. When each of the proteins required for acetylation
were mutated, wssFGHIJ, the resulting biofilm phenotypes were noticeably different. One of
these mutants was designated WS-18 where a mini insertion was located on the wssF gene (64).
Analysis of the polar mutants, mutations that affect expression of downstream genes, showed
that when any of the proteins were removed from the system it caused a disruption in Oacetylation of the polymer. Without the proper cohesion, provided by polymer modification, the
bacteria are unable to form a thick biofilm, as seen with the wildtype. Non-acetylated cellulose is
more disorganized and less cohesive, resulting in the cellulose polymer displaying a decrease in
mechanical protection for the community (84). Those bacteria unable to successfully form/join
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biofilms are more susceptible to antibacterial compounds or sudden changes in environmental
forces (e.g. rain or rivers current) (36, 37). As such the presence of a strong biofilm is important
for the success of many bacterial communities as they explore nutrient rich, yet dangerous
locations. (28, 64, 85). As such, it is important for the biofilm to have an organized and cohesive
structure, which in the case of cellulose is often dependent upon acetylation.

Figure 1.7 Comparison of biofilm formation. Wildtype air-liquid interface P. fluorescens
biofilm (left) compared against WS-18 (WS mini-Tn5::wspF – wssFGHIJ polar mutant) biofilm (right).
(28))

While beneficial, O-acetylation of a polymer is a complex process. As seen previously
(Figure 1.6), multiple proteins can be required for polymer modification. This is because Oacetylation of materials, like cellulose or alginate, requires more than one reaction (86). First, an
enzyme must remove the acetate from a donor and transport it through the inner membrane into
the periplasmic space. To facilitate this one or more membrane bound O-acetyltransferases
(MBOATs) are required (70, 86, 87). Next the acetate must be transferred onto the growing
polymer. Once more this is achieved one of several ways, in the case of the wss system it is
believed to rely on multiple periplasmic proteins that function as O-acetyltransferases WssFGI
(28, 69). To predict how the Wss acetyltransferase system works it helps to look at the Alginate
system where a “bi bi ping pong” or double displacement system has been described for AlgX
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and AlgJ (88). This reaction proceeds in two steps; AlgJ utilizes an esterase reaction to remove
the acetate from a donor, which allows AlgX to catalyze the O-acetylation of the growing
alginate polymer (70). Which Wss enzymes contribute to each part of the O-acetylation of
cellulose is still unknown.

2. Research Need
Tomatoes are a significant economic crop for North American Countries, within the US
tomatoes account for $2 billion in annual farm cash receipts (20). In Canada vegetable crops in
2016 were valued at $1 billion with carrots and tomatoes representing over $100 million in crops
each (89). Microbial biofilm forming species, such as, P. fluorescens, are capable of improving
crops yields through increased nutrient utilization (90, 91). With increased nutrients accessible to
crops these bacteria expand the growing regions of crops into otherwise arid or uncultivatable
lands. Additionally these bacteria are protecting against fungal infestation (17, 18, 92).
Protection against tomato and radish wilt, as mentioned before, will greatly increase yields and
therefore profits. Pseudomonas spp. have been found to restore seedling emergence in tomato
plants infected with Ralstonia solanacearum (92). Treated plants found 75 % seedling
emergence compared to untreated plants with 40 % emergence, which was almost a full
restoration with uninfected controls at 76 %. Beyond the economic benefits, concern for P.
fluorescens is warranted from a healthcare perspective. P. fluorescens has largely been
overlooked as its universal presence in places like plant soils and waste drainage is well known
(93). However, recent research has discovered the ability of P. fluorescens to cause infections
within immunocompromised hosts (94–97).
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The most common population for chronic infection globally are cystic fibrosis (CF)
patients (98). Infection rates of cellulose biofilm-forming Achromobacter species vary among CF
patients: A. xylosoxidans rates vary from 17 % in Belgium (99) to as high as 20 % in Brazil,
(100) while A. insuavis infections in the UK has been reported at 12 % (101). The global impact
of CF is significant, as 1 in 3500 children are born with CF in the United States, which
corresponds to more than 85,000 sufferers (98). However, immunocompetent populations are
also at risk of infection notably observed in the case of contact lenses as mentioned previously.
With the ubiquity of acute and chronic infections by bacterial species like Pseudomonas and
Achromobacter it is important to understand what mechanisms they utilized to survive.
As one of the major survival mechanisms employed by bacteria, biofilms and specifically
modified EPS are an important area of study. In particular the acetylation of cellulose, in P.
fluorescens and A. insuavis, can be studied through elucidation of the WssGHIF cassette.
Mutants of wssF have shown the encoded protein is required for the production of acetylated
cellulose (28). However, due to a lack of structural and functional data, the role of WssF in
acetylating cellulose remains biochemically uncharacterized. Our hypothesis is that
characterizing the structure and function of WssF will confirm its function as an
acetyltransferase that infers its role as a cellulose modifying enzyme in the cellulose
biosynthetic apparatus.
To address our hypothesis, we will perform the following objectives:
Objective #1: Protein expression and purification of the WssF A. insuavis and P. fluorescens
constructs.
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Objective #2: Perform a functional analysis of both WssF constructs for acetyltransferase
activity. Functional characterization of esterase activity will be achieved through colour and
fluorescence spectrometry. Transferase activity will be characterized through Thin-layer
chromatography (TLC) and Mass Spectrometry of treated cellulose samples. Finally, profiles
will be created against known inhibitor compounds as well as High Throughput Screening (HTS)
on vast libraries of potential inhibitors.
Objective #3: Perform a structural analysis of both WssF constructs through a combination of
X-ray crystallography and small-angle scattering experiments.

3. Material and Methods
3.1 Reagents, Chemicals, and Media
The chemicals purchased from Fisher Scientific were sodium chloride,
tris(hydroxymethyl)aminomethane (Tris), Coomassie R250, acetic acid, methanol and glacial
acetic acid. Fisher Bioreagents was used to purchase both Tetramethylethylenediamine
Dithiothreitol (DTT) and Sodium Dodecyl Sulfate. From Fisher Chemical sodium phosphate
mono- and dibasic were purchased. The products purchased from BioBasic were Tryptone
powder, isopropyl β-D-1-thiogalactopyranoside (IPTG), yeast extract, kanamycin sulfate, agar,
glycerol and, ammonium persulfate. From BioShop Imidazole, RNaseA and, DNaseI, Protein
Ladder and, Acrylamide/Bis-Acrylamide (29:1) 30 % (v/v) solution were purchased. A Precision
Plus ProteinTM Dual Color Standard was purchased from Biorad. The His-pur Ni-NTA Resin
used for purification was purchased from Thermo Scientific. For plasmid preparation a QIAprep
Spin Miniprep Kit was purchased from Qiagen. Vivaspin centrifugal ultrafiltration devices were
obtained from GE healthcare. The crystal screens Top 96, MCSG-1, 2, 3, and 4 were purchased
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from Microlytic. The 96-well INTELLI-PLATEs were purchased from Art Robbins Instruments
while Crystal Clear sealing tape was obtained from Hampton Research. Both cellulose and chito
oligomers were purchased from Megazyme. Any reagents or chemicals not listed above were
purchased from Sigma-Aldrich. When culturing E. coli there were two medias used primarily.
When culturing stocks overnight LB or Luria Bertani broth was used. which contained 10 g/L
tryptone, 5 g/L yeast extract and 10 g/L sodium chloride. LB agar plates were made by adding
1% (w/v) agar. When growing cultures for expression a Super Broth or SB media was used.
which contained 32 g/L tryptone, 20 g/L Yeast Extract and, 10 g/L sodium chloride. Any media
containing kanamycin sulfate or chloramphenicol were made to a concentration of 50 µg/mL.

3.2 Bioinformatics analysis of WssF
In order to begin elucidating WssF multiple programs were used to analyze the sequence
of WssF for a predictive model. One such program was Protparam, which utilized the amino acid
sequences found in Appendix A to predict various chemical and physical features of WssF
(102). This process of analysis was also utilized for each of the constructs ordered or generated
in lab (Appendix A). After Protparam, the sequences were further analyzed with the help of the
BLAST (Basic Local Alignment Search Tool) servers (103). With the use of BlastP, a program
used to search protein databases, the FASTA sequence of WssF was compared for homology
against other proteins, including acetyltransferases, in order to predict possible active residues
and regions containing similar structures. Through the use of Phyre2 (Protein
Homology/AnalogY Recognition Engine Version 2) the FASTA sequence of WssF was used to
create a predictive three dimensional model (PDB or Protein Data Bank file) of the proteins
structure based on homology detection (104). The Consurf program was then used to determine
amino acid conservation against potential homologues (105, 106). Consurf utilized PSI-Blast
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(Position-Specific Iterative Basic Local Alignment Search Tool) to collect homologues from the
UniProt database and the program Muscle for multiple sequence alignments (107–109). As a
result, a conservation scoring system was used to colour code the Phyre2 predictive model (.PDB
file) based on specific amino acid conservation. In order to visualize the predictive model, with
conservation colouring, Pymol was used to display 3D models, which would be used to direct
research decisions (110).

3.3 Expression and Purification of WssF
3.3.1 Isolation and replication of wssF plasmids
Two wssF genes were ordered from Genscript, with a pET24 C-Terminal His6 tag, one
from Acromobacter insuavis (pJPJTW5) and the second from Pseudomonas fluorescens
(pJPJTW3). Plasmid stocks were replicated by inoculating E. coli Top 10 cells, grown in a Super
Broth (supplemented with 50 µg/mL kanamycin) at 37 ˚C for 16 h. A Plasmid Mini prep kit
(Axygen, Union City California or Qiagen: QIAprep Spin Miniprep Kit) was used to prepare 50
µL plasmid aliquots with roughly 180 ng/µL of DNA. These samples were stored at -20 ˚C until
needed.
A 2 µl aliquot of wssF plasmid (pJPJTW5 or pJPJTW3) was transformed into CaCl2 E.
coli BL-21 competent cells (Novagen) using the standard heat shock method (111). Plasmid was
added to a standard 1.5 mL microcentrifuge tube containing 100 µL of BL-21 competent cells,
which was then incubated at 4 °C for 30 min. The sample was heat shocked (32 ˚C) for 1.5 min,
before being left at 4 °C for 5 min. After mixing for 5 min the sample was added aseptically to
500 µL of pre-warmed (37°C) LB broth and incubated at 37 °C for 1 h shaking at 220 rpm. After
transformation the cells were plated on LB agar (50 µg/mL kanamycin and chloramphenicol)
before being incubated for 16 h at 37 °C. A single colony was taken from the plated cultures to
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inoculate new cultures, of LB with a kanamycin and chloramphenicol concentrations of 50 µg/L.
Cultures were used to create stocks of the transformed BL21 cells (cell cultures containing 15 %
(v/v) glycerol) and stored at -80 ˚C until needed for future inoculations.
3.3.2 Expression of WssF
Protein expression proceeded with the goal of optimal production of carbon terminal
tagged His6 WssF proteins for A. insuavis (AiWssF) and P. fluorescens (PfWssF). In order to
achieve this goal, overproduction of each protein was accomplished through the use of
transformed E. coli BL21 (pET24) cells. Cultures were grown for 16 h at 37 ˚C shaking at 220
rpm and then used to inoculate larger SB cultures (1/50) for expression. Cultures grew at 37 ˚C
shaking at 220 rpm until an OD600nm of 0.6 was reached and then Isopropyl β-D-1thiogalactopyranoside (IPTG; Biobasic) was added to a final concentration of 1 mM to induce
expression from the pET plasmid constructs through activation of the T7 RNA polymerase
within the lac operon. (112, 113) Induced cultures were grown for 16 h at 220 rpm and 30 ˚C.
Post induction, the bacterial cultures were subjected to centrifugation for 15 min at 5000 x g and
4 ˚C. The supernatant was decanted, and cell pellets were stored at -20 ˚C until required for
purification.
3.3.3 Purification of WssF
Lysis buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 2 % (v/v) glycerol (Biobasic)) was
used to suspend thawed cell pellets. The cell suspension was then lysed through mechanical
pressure using a cell disruptor (Constant Cell Disruption Systems, Deventry United Kingdom) at
17.4 kPsi with one passage through the system. The cell lysate was subjugated to centrifugation
for 45 min, at 28 000 x g and 4 ˚C, to remove the insoluble fraction that included inclusion
bodies. The clarified supernatant was subjected to Immobilized Metal Affinity Chromatography
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(IMAC) for the purification of His-tagged proteins (114). Briefly, the supernatant was mixed
with 1 mL of His-pur Ni-NTA Resin (Thermo Fisher Scientific) for 1 h. The sample was then
applied to an open column and the resin was washed first with 25 mL of Lysis buffer followed
by 25 mL of wash buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 % (v/v) glycerol, 50 mM
imidazole (Bioshop)). Elution of bound protein from the column was accomplished by applying
5 mL of Elution buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 2 % (v/v) glycerol, 500 mM
imidazole) to the column and allowing it to incubate with the column for 10 min prior to elution.
The elution fractions containing WssF (24.6 kDa) were concentrated using 10 kDa molecular
mass cut off filters (Vivaspin) to a volume of 1 mL by subjecting the samples to centrifugation at
4000 x g at 4 ˚C. Due to the size of the WssF proteins they would not pass through the filter
allowing for the sample to be concentrated. Filtered samples were additionally subjected to
centrifugation for 10 - 15 min at 13 400 x g at 4 ˚C to remove any insoluble particulate or
precipitate. Buffer exchange was performed to remove the imidazole and exchange the 50 mM
pH 8.0 Tris-HCl for 50 mM pH 7.0 Sodium Phosphate buffer. Other concentrations, such as,
NaCl and glycerol, remained constant. Purified protein following these steps was assessed from
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) analysis, and routine
functional assays were used with protein purified to this level. Protein concentrations were
determined through the use of a Cytation 5 Cell Imaging Multi-Mode Reader (Biotek), which
utilized the Beer lambert law of Ɛ=clλ where the extinction coefficient (Ɛ) 47690 M-1 cm-1 of
WssF against absorbance measurements (λ) at 280 nm with a constant pathlength (l) of 1 cm.
For structural analyses, protein was further purified by fast protein liquid chromatography
(FPLC) with a SuperDex 75 Size Exclusion column (SEC) to separate out contaminants based on
size. Following equilibration of the SEC column in Gel filtration buffer (50 mM Tris-HCl pH
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7.4, 150 mM NaCl, 2 % Glycerol (v/v)), 1 mL of protein sample was applied to the column with
a flow rate of 1 ml/min (115). Fractions were collected in 2 mL aliquots and WssF-containing
fractions eluted reliably from the column in the 11-14 mL fractions. SDS-PAGE was used to
confirm the presence and purity of protein in all fractions.
3.3.4 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
SDS-PAGE was used to determine the presence and purity of WssF throughout
purification. SDS-PAGE gels were performed using standard procedures to separate molecules
based on molecular mass. (116, 117) Routine gels consisted of a 12 % (v/v) separating gel (2 mL
Acrylamide/Bis-Acrylamide (29:1) 30 % (v/v) solution (Bioshop), 1.675 mL of ddH2O (double
distilled water), 1.25 mL of 1.5 M pH 8.8 Tris-HCl, 50 µL of 10 % (w/v) SDS, 25 µL of
Ammonium persulfate (Biobasic), 5 µL of Tetramethylethylenediamine or TEMED (Fisher
Bioreagents)) and a 4 % (v/v) stacking gel (0.65 mL Acrylamide/Bis-Acrylamide (29:1) 30 %
(v/v) solution, 3.05 mL of ddH2O water, 1.25mL of 0.5M pH 6.8 Tris-HCl, 50 µL of 10% (w/v)
SDS, 25 µL of Ammonium persulfate, 10 µL of TEMED). Purification fractions were mixed
with 5 times concentrated SDS sample buffer, containing 1.54 µg/ml Dithiothreitol (DTT), in a
1:1 ratio. Mixed samples were heated to 90 ˚C for 10 min to denature the protein, cooled and
then loaded onto the gel along with Precision Plus ProteinTM Dual Color Standards, that was used
as a mass comparison. After running, at 200 V for 45 min, the proteins in the gel were stained
with Coomassie brilliant blue (0.1% (w/v) Coomassie R250, 10% (v/v) acetic acid and, 40 %
(v/v) methanol) and destained in destain solution (10% (v/v) glacial acetic acid, 20 % (v/v)
methanol and, 70 % (v/v) water) until the desired contrast was achieved (116).
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3.4 Functional Characterization of WssF
3.4.1 Esterase activity assays
Routine monitoring and functional characterization of WssF activity was achieved using
the colorimetric substrates 4-nitrophenyl acetate (pNP Ac) and 4-methylumbelliferyl acetate (4MUB Ac). Assays were done in quadruplicate unless otherwise stated. Standard assays (unless
noted otherwise elsewhere) consisted of using a pNP Ac substrate and were conducted in 96 well
microtiter plates (Sarstedt) read at an absorbance of 405 nm (Cytation5) for 30 min in 1 min
intervals following a 5 s initial linear shake to mix contents thoroughly. For 4-MUB Ac assays
were tested in fluorescence compatible 96-well plates (Grenier BioOne) with excitation and
emission wavelengths of 365 and 450 nm, respectively, used to monitor the assay. Esterase rates
were corrected for the background rate of spontaneous hydrolysis of the substrate used. All
assays were designed to minimize differences in well conditions between assays and run in
quadruplicate unless otherwise specified. Well conditions had a maximum volume of 300 µL.
Common Assay Conditions were 50 % (v/v) 100 mM pH 7 Sodium Phosphate (Fisher
Chemical), 5 % (v/v) 4 µM protein (2mg/mL stock), 5 % (v/v) pNP Ac (EtOH) or 4-MUB Ac
(DMSO) 80 mM stock, 40 % (v/v) ddH2O water. pH 7 Sodium Phosphate buffers were made
with 9.75 mL of 200 mM monobasic Sodium Phosphate, 15.25 mL of 200 mM dibasic Sodium
Phosphate and, 25mL of H2O. Assays were initially done with a maximum volume of 300 µL
before being scaled down to 150 µL and 94 µL. Scaling of the assays allowed for less protein
consumption, which allowed for more assays and/or replicates per mL of purified protein.
Specific activity was reported as 1 unit of esterase activity, which was defined as the amount of
enzyme required to release a µmol of p-nitrophenol min-1 (mg of protein)-1.
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3.4.1.1 Storage profiles
Short and long-term storage profiles were developed for both WssF constructs. Assays
were conducted with 4-MUB Ac as substrate. When samples were stored at -20 ˚C or -80 ˚C the
final well conditions contained 10 % (v/v) glycerol in place of an equal volume of ddH2O water.
3.4.1.2 pH Profile

A pH profile of both WssF constructs was investigated to determine the optimal pH and
buffer for activity assays. A 2-(N-morpholino) ethanesulfonic acid (MES) buffer was chosen
between pH ranges of 5.5 - 6.5, sodium phosphate buffer for pH of 6.5 - 7.5 and Tris buffer for
the final range of 7.5 - 9.25. The assay was performed in quadruplicate with 50 mM buffer of
each of the various pH values in the presence of 4 μM purified WssF, and 6 mM pNP-Ac. The
data are presented as percent activity of WssF compared to the highest value at pH 8.5.
3.4.1.3 Inhibitor Profile

An inhibitor profile was performed to determine if the compounds
phenylmethanesulfonyl fluroide (PMSF) (a serine protease inhibitor), methanesulfonyl fluoride
(MSF) (an acetylcholinesterase and serine protease inhibitor) and EDTA (metal chelator), would
elicit any inhibition of WssF. Assays were completed using 5 mM pNP Ac as substrate after a 1
h incubation at 22 ˚C. All compounds were tested against both constructs with inhibitor
concentrations ranging from 0 mM to 5 mM while maintaining 5 % (v/v) final well volume of
inhibitor in place of an equal volume of ddH2O.
3.4.1.4 Acceptor Profile

An acceptor profile was done on both WssF constructs using 4 mM pNP Ac as substrate.
The acceptors utilized were cellobiose, cellotriose, cellotetraose, cellopentaose and cellohexose.
Following this, varying lengths of a Chito-oligomer, from chito-biose to chitohexaose, was used
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to test for the specificity of WssF. In both cases acceptor concentrations of 1 mM were attained
while maintaining final well volume of 5% (v/v) acceptor replacing an equivalent volume of
ddH2O.
3.4.2 Site Directed Mutants
Ser17, Asp188 and, His191, were replaced with Ala by site-directed mutagenesis of the
A. insuavis wssF gene. Primers used for this mutagenesis are listed in Table 3.1 mutagenesis was
carried out using JPJTW5 as a template for pfu Turbo DNA polymerase according to the
QuickChange site-directed mutagenesis kit. Following PCR, 1 mL of Dpn1 was added to a 50 μL
PCR mixture and incubated for at least 1 h at 37 °C to remove the original, methylated template.
The resulting plasmids were used to transform TOP10 Chemically Competent E. coli, and clones
were screened for the correct mutations by DNA sequencing. Each of the protein products was
purified to apparent homogeneity, as described above for wild-type AiWssF. New purification
buffers were used for each mutant purification to avoid potential contamination of the various
mutant forms of the enzymes with each other.
Table 3.1 SDM Primers sequences. Primer sequences for mutants AiWssF S17A, D188A and, H191A.
Mutation
Primer sequence (5ʹ-3ʹ)
AiWssF_S17A Fwd CTGCTGATCGGTGATGCCCATCTGGCGGCCCC
AiWssF_S17A Rev
GGGGCCGCCAGATGGGCATCACCGATCAGCAG
AiWssF_D188A
Fwd
GGCCGACCACCGAGGTCAGCACTATACCAATACGGGC
AiWssF_D188A
Rev
GCCCGTATTGGTATAGTGCTGACCTGCGGTGGTCGGCC
AiWssF_H191A
Fwd
GGCCGACCACCGATGGTCAGGCTTATACCAATACGGGC
AiWssF_H191A
Rev
GCCCGTATTGGTATAAGCCTGACCATCGGTGGTCGGCC
*Highlighted codon represents the alanine point-mutation
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3.4.3 Thin Layer Chromatography (TLC)
In order to test whether both constructs were capable of cellulose modification Thin
Layer Chromatography (TLC) was utilized. After running a specific activity assay on either
construct in the presence of cellulose as an acceptor for 24 h, samples were filtered using
CarboGraph Columns. The activated carbon columns required a preparation protocol before
samples could be filtered to remove everything except the cellulose (Appendix B). The
Preparation protocol utilized 1 column volume (CV) of 100 % (v/v) acetonitrile and 2 CVs of
ddH2O. At this point the column was ready to filter the samples using a filtration protocol
(Appendix B). Briefly, reaction samples were diluted by adding 150 µL of sample to ddH2O to
create a 1 mL final volume. The diluted mixture was added to the column for absorption before a
2 CV wash with water and 1 CV elution with 50 and then 100 % (v/v) acetonitrile. After
collecting the elution of cellulose, the activated carbon columns were cleaned with a CarboGraph
cleaning protocol (Appendix B). Briefly, columns were cleaned using 2 CVs of 50 % (v/v)
Tetrahydrofuran (THF) and washed with 2 CVs of ddH2O. Finally, TLC was performed on the
now filtered samples of cellulose (Appendix B). A 10 x 10 cm aluminum-backed silica TLC
plate was spotted with samples using precision capillary tubes (0.4 mm x 75 mm). An 8:3:4
Mobile phase (53.33 mL ethyl acetate, 20 mL ddH2O, 26.67 mL Methanol) was used to separate
samples in a rectangular developing chamber (General GlassBlowing Company Inc.). Following
separation, the plate was air-dried and sprayed using a 25:3:2 Naphthol Stain (208.33 mL
Methanol, 25 mL H2SO4, 16.67 mL ddH2O) before being heated to 100 °C for visualization of
the stain. Images were taken in top light mode in a Versadoc molecular imager (Biorad).
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3.4.4 Mass Spectrometry
Following TLC, 75 µL (approximately 300 µM) of the cellulose samples, filtered through
the active carbon columns, were sent for mass spectrometry. All samples sent for mass
spectrometry were filtered through activated carbon columns in order to retain only the modified
or unmodified cellulose sample. The samples were analyzed at the University of Guelph by
Dyanne Brewer on a Bruker AmaZon SL LC-MSn instrument (118). Negative controls and 24 h
time point samples were sent for both AiWssF and PfWssF constructs. Following this each of the
AiWssF site direct mutants (S17, D188, H191) and the previous AiWssF wild type as a control
control sample were sent for mass spectrometry. The size range scanned began at 400 m/z and
ended at 1000-1200 m/z, which allowed for identification of both modified (850 Da) and
unmodified cellulose (828 Da) adducts.
3.4.5 High Throughput Screening
While attempting to structurally and functionally elucidate WssF, stocks of AiWssF
protein (2 mg/mL) were sent to the SPARK facility at the University of Toronto. High
Throughput Screening (HTS), done by Leanne Wybenga-groot, was utilized in determining
potential inhibitory compounds. Fluorescence assays were run on 384-well microplates using 4MUB Ac as an acetate donor analogue. Before any inhibitor compounds were added to a screen
Zʹ scores were determined for positive control plates. Next a set of control plates were left with
protein at room temperature to be read periodically throughout the day. Well conditions
contained 50 mM pH 7 sodium phosphate with 0.3-1.5 µM AiWssF protein with 0.5 mM 4MUB Ac at 5 % (v/v) DMSO of the final well volume of 47 µL. These plates were to control for
any loss in activity seen throughout the day and determine the effect on Zʹ values. In addition,
the control plates were used to determine if wells closest to the edge of the plate would see non-
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uniform readings. Finally, when measuring the inhibitory effect of various compounds on
esterase activity, Z scores were taken after 10 minutes a sufficient amount of time for the Zʹ of
the reaction to reach a reliable threshold of 0.7. In other words, the reaction was allowed to
procced far enough for a sufficient difference between the positive and negative wells to produce
a large statistical difference or effect. A 2 µL aliquot of compound was added to each well for a
final concentration of 10 µM. Positive control wells were 1A - 1P and 2A - 2P, which lined one
end of the plate, while wells 23A - 23P and 24A - 24P were used as negative controls lining the
opposite end of the plate. Primary screening of approximately 64 000 compounds was performed
in single trials and was followed by secondary screening of 103 hits (in triplicate) along with the
addition of potential inhibitors, for similar putative acetyltransferases (WssI, PatB and, OatA),
resulting in a total secondary screen of 146 compounds. Next, dose response screens were
conducted on 83 compounds from the secondary screen. Dose response assays tested each of the
selected potential inhibitory compounds from 0-100 µM. Finally, 18 compounds were selected
for in-house testing, where dose response assays were run with 3 µM protein concentration.

3.5 Structural Characterization of WssF
3.5.1 Crystallization and Diffraction
Efforts to structurally characterize WssF focused initially on crystallography. Multiple
screens were used in an attempt to find successful crystallization conditions. Crystal reservoir
solutions were created from Top 96, MCSG-1, 2, 3, and 4 (Microlytic) premade formulations
with the addition of AiWssF (pJPJTW5) protein. Protein stocks of AiWssF were comprised
primarily of the buffer used during SEC (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 % (v/v)
Glycerol). The screens were created using a Gryphon 96 head dispenser (Art Robbins
Instruments) to dispense the 96-well plate screens in an efficient and organized manner. 1 - 2 µL
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of protein (10 - 29 mg/mL) was added to create a sitting drop with 1 - 4 µL from the well
condition. The reservoir of each well contained 60 µL of a condition obtained from the
preformulated screens. Crystal screens were observed, using an Olympus SZX16
Stereomicroscope, for successful crystal hits.
Successful crystal hits were then frozen, so they could be sent to the Canadian Light
Source (CLS) for X-ray diffraction analysis. In order to cryo-protect the crystals, 50% (v/v)
glycerol was added to the drop were the crystal was located. Next the crystals were picked or
scooped out of their drops using a loop from Mitegen. Next, the crystals were submerged into a
second premixed drop (1:1, reservoir solution: 50 % (v/v) glycerol). Finally, the loop and crystal
would be placed into a container of liquid nitrogen for flash freezing and storage until analysis at
the CLS. Diffraction data sets were collected using synchrotron radiation on the 08B1-1
beamline at the Canadian Macromolecular Crystallography Facility (Canadian Light Source
(CLS), Saskatoon) using a CCEL MD2 microdiffractometer and MarMosaic mx300 CCD X-ray
detector. Typical datasets at the CLS consisted of 360 images at 1˚ oscillations with a 250 nm
crystal-to-detector distance and an exposure time of 0.2 s per image. The data were integrated,
reduced and scaled using AutoProcess (119). Additional datasets were also collected at the
University of Waterloo using a Rigaku rotating copper anode X-ray generator and an R-axis
IV++ detector. These datasets consisted of 360 images at 1˚ oscillations with a 275 nm crystalto-detector distance and an exposure time of 2 min per image. The data were integrated and
scaled using HKL-2000 (120).
Expansion plates were made manually to recreate and expand on the previously
successful conditions. Examples of expansion plate layouts can be found in Appendix B.
Gradients of PEG concentration and protein concentration were created directly around those
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used in the successful crystal conditions. For the Top 96 formulations, protein concentrations of
17, 15 and, 13 mg/ml were used with PEG 3350 concentrations of 20, 23, 25, 27 and, 30 % (w/v)
to create an expansion of the successful condition. To expand the conditions of well H10 from
MCSG1 protein concentrations 29.5 and 25 mg/ml were used with PEG concentrations of 20, 23,
25, 27 and, 30 % (w/v). Next, an expansion of well condition F1 from screen MCSG1 was
created from mixing 29.5 and 25 mg/ml with PEG 3350 concentrations of 15, 18, 20, 22, 25 %
(w/v). In addition to changing protein concentration a set of expansion plates were made with
variations of pH and PEG concentrations. PEG concentrations ranged from 19 to 31 % (w/v)
with pH ranging from 5.6 to 8.4.
3.5.2 Molecular Replacement
Molecular replacement was attempted to solve phases for structure determination. The
primary molecular replacement programs used were MRage and/or Phaser modules of the Phenix
suite (121). Alternatively, automated molecular replacement was also attempted through the
CCP4 online interface with the BALBES, MrBump, and MoRDa programs (122–125). Either
way molecular replacement was conducted using PDB files from structures with possibly
significant levels of homology to AiWssF found in Phrye2 and BLASTP searches, the top 5 hits
were recorded and analysed for possible usage (see Tables 4.2 and 4.3 in the Results section).
3.5.3 Small Angle X-Ray Scattering
While working on solving the phase problem, efforts were made to determine generic
structural characteristics through the use of Small Angle X-Ray Scattering or SAXS. This was
achieved by sending protein samples (1, 5, and 10 mg/mL) to the SIBYLS beamline (12.3.1) at
the Advanced Light Source part of the Lawrence Berkeley National Laboratory (126). The X-ray
wavelength was 1.0 Å, with a flux of 1013 photons per second, and a sample-to detector distance
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of 1.5 m. Scattering images were collected using a Pilatus 2 M detector every 0.3 s, with a total
of 33 samples images. All sampling was performed at 10 °C on multiple samples at various
protein concentrations (1, 5, and 10 mg/mL) to remove concentration-dependent patterns (127).
Negative control samples were also collected for background subtraction (128, 129). Every
collected image was circularly integrated then normalized for beam intensity to generate a 1dimensional scattering profile. Background subtraction of each profile was done against the
negative controls to give two background subtracted sample profiles. Averaging of the subtracted
profiles was achieved through the use of Frameslice (with the assistance of William Scott,
Weadge Lab).
With the SAXS profiles corrected for concentration dependence and background
intensities, further analysis was required for interpretation of the data. SCÅTTER was used to
generate Rg (radius of gyration), Rc (cross-sectional radius), Q (Porod volume), and Dmax
(Dimension Maximum) values that best matched the averaged and background subtracted 1dimensional scattering profiles (130, 131). These values were determined through linearization
of the scattering profiles to create scatter curves and pattern models (132). Multiple automated
transformations and calculations were applied to the scattering profiles (Guinier, Zimm, Holtzer,
Kratky, Porod). From here the values obtained from SCÅTTER were exported to GNOM.
GNOM was used to adjust where along the scatter curve the 3D model would begin and end
processing of the SCÅTTER profile. GNOM provided a total estimate value, which varied from
0 to 1, with 1 representing ideal P(r) (Pair distance distribution function), Rg and, I0 (Molecular
mass) values (133). The total estimate value was used to determine the optimal positions to start
and end modelling of the scatter curve.
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Generation of 3D models required multiple programs for imaging and conversion. First
the program GASBOR was used to image the 3D model parameters refined in GNOM (134).
GASBOR operated through the online data analysis server ATSAS 2.8.4 (135). Finally,
DAMAVER, run through the SIBYLS beamline website for SAXS applications, was utilized in
conjunction with GASBOR to produce averaged PDB files that were visualized in Pymol (136).
Once exported to Pymol the legacy plugin SASpy was used to compare and orient the
SAXS model to the Phyre2 model previously created (137). SASpy function crysol was used to
fit the SAXS data with the predictive model while the functions sasref and supalm were used to
refine and superimpose the two models respectively.

4. Results
4.1 Bioinformatics
Bioinformatic analysis for both A. insuavis and P. fluorescens full length WssF proteins
and C terminal His6 constructs was completed. Protparam was used to determine various
properties for all four sequences. As can be seen in Table 4.1, molecular mass (23495 24560.1Da), theoretical pI (8.79 - 8.58), extinction coefficients (47690M-1 cm-1) and absorbance
(2.03 - 1.942 g/l) were all predicted based on the primary amino acid sequences (provided in
Appendix A). Both full proteins and His6 tagged constructs were predicted to be stable with
instability scores ranging from 21.51 to 22.65. Of note, each construct analyzed had four cysteine
residues and six methionine residues. Cysteine residues are important to consider as they can
participate in disulfide bond formations that effect the folded structure of the protein (138). A
disulfide bond has been found in AlgX a homolog of WssF (69). Finally, Methionine residues
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would be instrumental in deciding how to proceed during structural characterization
(Selenomethionine) (139).
Table 4.1 ProtParam Protein Output. Predicted chemical and physical features for Full Ai/Pf WssF
Proteins and C terminal His6-tagged constructs.
ProtParam Output
Number of amino acids
Molecular mass
Theoretical pI
Extinction coefficients (in units of M-1 cm1
, at 280 nm measured in water)
Absorbance (g/l)
Instability index
Cystine residues
Methionine residues

AiWssF
Full
protein
221
23495
8.79
47690

AiWssF
pET24CtermHis6
229
24560.1
8.58
47690

PfWssF
Full
protein
221
23495
8.79
47690

PfWssF
pET24CtermHis6
229
24560.1
8.58
47690

2.03
22.4
4
6

1.942
21.26
4
6

2.03
22.65
4
6

1.942
21.51
4
6

Primary amino acid sequences were also utilized to predict the functionally of the WssF
proteins. Comparing the amino acid sequence of WssF against the National Center for
Biotechnology Information’s (NCBI) Conserved Domain Database (CDD) predicted an
oxyanion hole formed by residues 17 (Serine), 69 (Glycine) and, 103 (Threonine) (140). The
CDD also predicted a catalytic triad formed by residues 17 (Serine), 188 (Aspartic acid) and, 191
(Histidine). These predictions are made based on the conservation of specific amino acids
compared to a position-specific score matrices or PSSM (140, 141). Proteins are then placed into
families, within the NCBI database, that share functionality and sequence conservation. As a
result of the CDD predictions, WssF is predicted to share functionality with the SGNH hydrolase
family, which also contains members of an acetyltransferase subgroup (AlgX in particular) (69).
Active site prediction based on sequence alignment supports the possibility that WssF proteins
are capable of esterase activity. Ester hydrolysis would be required as the first step in the
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functionality of WssF as an acetyltransferase. In order to further support this hypothesis, tertiary
structure models and amino acid conservation scores were determined. Phyre2 was used to
model a hypothetical structure for both truncated WssF constructs based on the provided amino
acid sequences. Low sequence identity was achieved with the highest matches reaching 19% for
AiWssF and 18% for PfWssF (Tables 4.2 and 4.3). For those that had the highest identity,
confidence was close to 99% with 90% coverage.
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Table 4.2 Top 5 Phyre2 Predicted Homology Results for AiWssF.
PDB
1.c2o14A

Coverage
(%)
89

Confidence % i.d.
(%)
99.9
16

PDB molecule

PDB title

hypothetical protein
yxim

X-ray crystal structure of protein
yxim_bacsu from bacillus2
subtilis. northeast structural
genomics consortium target3
sr595
Crystal structure of a gdsl-like
lipase (bdi_0976) from2
parabacteroides distasonis atcc
8503 at 1.93 a resolution
Crystal structure of isoamyl
acetate-hydrolyzing esterase
from2 saccharomyces cerevisiae
Clostridium thermocellum family
3 carbohydrate esterase
Crystal structure of
psychrotrophic esterase esta
from2 pseudoalteromonas sp.
643a inhibited by3
monoethylphosphonate

2.c3p94A

92

99.9

13

gdsl-like lipase

3.c3milA

90

99.9

19

soamyl acetatehydrolyzing esterase

4.c2vptA

88

99.9

16

lipolytic enzyme

5.c3hp4A

88

99.9

17

gdsl-esterase

Table 4.3 Top 5 Phyre2 Predicted Homology Results for PfWssF
PDB

Confidence
(%)
99.9

% i.d.

PDB molecule

PDB title

1.c4lhsA

Coverage
(%)
87

18

uncharacterized
protein

2.c2o14A

93

99.9

17

hypothetical protein
yxim

3.c4iyjA

91

99.9

15

gdsl-like protein

4.c2vptA

88

99.9

18

lipolytic enzyme

5.c3p94A

89

99.9

16

gdsl-like lipase

crystal structure of a hypothetical
protein (bacova_00914) from2
bacteroides ovatus atcc 8483 at
1.40 a resolution
X-ray crystal structure of protein
yxim_bacsu from bacillus2
subtilis. northeast structural
genomics consortium target3
sr595
Crystal structure of a putative
acylhydrolase (bacuni_03406)
from2 bacteroides uniformis atcc
8492 at 1.37 a resolution
Clostridium thermocellum family
3 carbohydrate esterase
Crystal structure of a gdsl-like
lipase (bdi_0976) from2
parabacteroides distasonis atcc
8503 at 1.93 a resolution
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Next Consurf was used to determine amino acid conservation with potential homologues.
Consurf utilized PSI-Blast to collect homologues from the UniProt database and Muscle for
multiple sequence alignments. Conservation scores were determined utilizing the empirical
Bayesian paradigm, which is used to determine the rate of evolutionary conservation at each
amino acid site (142). Consurf scoring is broken down into 9 categories where 1 is the least
conserved and 9 is the highest conserved residues (105). Although a site may be rated the highest
conserved score this does not mean it is 100 % conserved only that it is the most conserved in the
sequence. Investigation of conservation among top homologues showed the highest conservation
scores of 9 for 17 (Serine), 188 (Aspartic Acid), 191 (Histidine) and surrounding residues, which
form the proposed active site of WssF. The hypothetical models were coloured from cyan (low
conservation) to purple (high conservation) and are represented in the WssI model in Figure 6.2.
All of the 50 closest homologues were predicted or are shown to be SGNH hydrolases, have
SGNH hydrolase like domains, or are an esterase of some form. This supports the possibility that
WssF has an SGNH hydrolase like domain, which facilitates the ability of the protein to
undertake esterase. Both constructs are also predicted to have the prototypical alpha/beta/alpha
fold of an SGNH esterase (Figure 4.1). However, the beta sheet of AiWssF is predicted to only
contain 4 parallel strands instead of 5, which normally make up the beta sheet found within
SGNH hydrolases. Surface models (Figure 4.1) show areas of high conservation within the
predicted active sites, which form a pocket within the hypothetical structure. Limited
conservation is seen throughout the surface models outside the predicted active sites representing
the low sequence identity previously determined.
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Figure 4.1 Phyre2 Predicted Structural Models of WssF. Phyre2 models of WssF (based on PDB:
c2o14A, 16 % amino acid identity) in its native state adopt an alpha/beta/alpha motif, shown in 2 separate
angles, for both P. fluorescens and A. insuavis constructs (A, & B). PfWssF cartoon model with stick
active site residues (A1), AiWssF cartoon model with stick active site residues (B1), PfWssF surface
model (A2), AiWssF surface model (B2). Each construct is colour coded using shades of purple to
represent high conservation and green to represent low conservation. All images were rendered in
PyMOL. (104, 110)

Analysis using Clustal Omega found a sequence alignment along the catalytic active site with
one deviation of a single nucleic acid site H191 (Figure 4.2). Models for AlgX (PDB:4knc
(yellow)) and AlgJ (PDB:4O8V(green)) were aligned with the predictive model of AiWssF
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(blue). The Carbohydrate binding module (CBM) domain of AlgX was removed to aid in
visualization of the three aligned protein models. As was expected the CBM domain of AlgX did
not align with either WssF or AlgJ. Normalized Spatial Discrepancy (NSD) values were
determined by SASpy for the alignment of WssF/AlgX (2.36) and WssF/AlgJ (2.23). Pymol
alignment of the models gave root-mean-square deviation (RMSD) scores of 13.86 for
WssF/AlgX, 4.78 for WssF/AlgJ and, 1.80 for AlgX/AlgJ. SASpy was used for model alignment
due to a better fit of the NSD values compared to RMSD values from Pymol alignment alone.

Figure 4.2 Three-Dimensional Alignment of WssF Homologs. Three-dimensional alignment of
predicted structure of WssF(blue), AlgX (PDB:4knc (yellow) and, AlgJ (PDB:4O8V) (Green). CBM
domain of AlgX has been removed for visualization. Conserved active site residues S17, D188 and, H191
are depicted in red to outline the predicted active site. Figure rendered in PyMol and superimposed by
SASpy. Normalized Spatial Discrepancy (NSD) value for WssF and AlgX alignment was 2.36. NSD for
WssF and AlgJ alignment was 2.23.
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4.2 Profile of Optimal Protein Expression and Purification (Objective 1)
4.2.1 Protein Expression
Bioinformatic analyses to predict the structure and function of WssF, was done
concurrently with optimization of protein expression and purification. Optimal protein
expression was determined through various trials, where the duration and temperature of
expression were found to be important. A wide range of temperatures for expression were
attempted and 16 ˚C, 26 ˚C and, 37 ˚C expressions resulted in insufficient protein production.
Expression at 30 ˚C for 4 h led to moderate protein production, whereas a 16 h expression at 30
˚C gave a strong band as seen in Figure 4.3.

A) Expression Duration Trials

B) Construct Comparison

Figure 4.3 SDS-PAGE Protein Expression of AiWssF and Pf WssF. SDS-PAGE analysis (12 % (v/v))
of AiWssF expression of 1 L cultures incubated at 30°C and 200 rpm (A). Lane 1, molecular-weight
markers (kDa); Lane 2, 16 h expression; Lane 3, 4 h expression. SDS-PAGE analysis (12 % (v/v)) of
AiWssF and PfWssF expression of 1 L cultures incubated for 16 h at 30°C and 200 rpm (B). Lane 1,
molecular-weight markers (kDa); Lane 2, AiWssF; Lane 3, PfWssF.
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4.2.2 Protein Purification
Both versions of WssF were subjected to an initial purification round that involved
immobilized metal affinity chromatography (IMAC) that took advantage of the His6 tags on the
C-terminus of the expressed constructs. Briefly, WssF was left to incubate with Ni-NTA resin.
Bound protein was then washed with increasing imidazole concentrations to remove binding
contaminates Figure 4.4. Purity of WssF during purification can be seen in Figure 4.4A and was
sufficient for functional characterization. After primary purification samples were typically
found to retain contaminate bands and a possible protein dimer, as seen in Lane 5 of Figure
4.4B. SEC through FPLC was used in an attempt to further remove contaminants and increase
the purity of the protein samples (Figure 4.4; Panel B, lane 6). Protein production yielded a
consistent 3 mg of purified protein per L of culture expressed when the optimal conditions were
met. With the successful and reliable production of protein from both constructs optimized,
there was enough protein for subsequent characterization assays (outlined in sections that
follow).
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A

B

Figure 4.4 SDS-PAGE Analysis of the Purification of Expressed WssF protein samples. SDS-PAGE
analysis (12 % (v/v)) of Ai and Pf WssF Ni-NTA IMAC purification fractions (A). Lane 1, molecularweight markers (kDa); lane 2, Ni-NTA column unbound lysate; lane 3, wash with lysis buffer (no
imidazole); lane 4, wash buffer (50 mM imidazole); lane 5, elution buffer (500 mM imidazole); lane 6,
Ni-NTA column unbound lysate; lane 7, wash with lysis buffer (no imidazole); lane 8, wash buffer (50
mM imidazole); lane 9, elution buffer (500 mM imidazole) Typical SDS-PAGE analysis (12 % (v/v)) of
AiWssF Ni-NTA IMAC purification fractions and Size Exclusion chromatography (B). Lane 1,
molecular-weight markers (kDa); lane 2, Ni-NTA column unbound lysate; lane 3, wash with lysis buffer
(no imidazole); lane 4, wash 1 (50 mM imidazole); lane 5, elution buffer (500 mM imidazole); lane 6,
combined SEC elution fractions.

4.2.3 Further Purification Optimization
Although a working optimum of protein yield had been achieved, time was also taken to
slowly determine improvements for yielding pure protein. A fresh plasmid preparation from a
Qiagen midiprep kit along with the use of Rosetta™ (DE3) Competent Cells found
improvements to protein purity and yield as seen in Figure 4.5. An added benefit was that the
potential dimerization band seen earlier was found to no longer exist.
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Figure 4.5 Purification of Expressed Ai/PfWssF protein sample. SDS-PAGE analysis (12 % (v/v)) of
Ai and Pf WssF Ni-NTA purification fractions. Lane 1, molecular-weight markers (kDa); lane 2, AiWssF
Ni-NTA column unbound lysate; lane 3, wash with lysis buffer (no imidazole); lane 4, wash buffer (50
mM imidazole); lane 5, AiWssF elution buffer (500 mM imidazole); lane 6, PfWssF elution buffer (500
mM imidazole).

4.3 Functional Characterization of WssF (Objective 2)
4.3.1 Verification of WssF Esterase activity
The mechanism of action for WssF was explored through various in vitro assays. As a
putative acetyltransferase the function of WssF was able to be tested in two separate reactions.
First hydrolysis would be required for initial cleavage of the acetyl donor substrate followed by
transferase activity or O-acetylation of cellulose. Predictions of potential active site residues,
based on homology of WssF with other O-acetylation proteins, made testing for esterase activity
the next logical step (69, 143). As such, purified protein was added to reaction mixtures with 4MUB Ac or 4-Nitrophenyl acetate (pNP Ac) acting as a substrate. Testing for the potential
esterase activity of WssF was done through adding increasing concentrations of protein to
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reaction mixtures containing a constant concentration of 2 mM 4-MUB Ac or pNP Ac (Figure
4.6). Changing the concentration of protein directly affected the concentration of 4methylumbelliferyl or 4-nitrophenol produced based on the shifts in the florescence and
colourimetric profiles. These results confirm that the esterase activity observed was due to the
presence of WssF, since the appropriate controls lacked this correlation, and that the substrates
could be measured consistently throughout the colourimetric assay. Assays were performed for
30 min, but only the linear portion of the curve was used for calculations in this and subsequent
sections. Specific activity values for AiWssF was determined for the hydrolysis of both 4-MUB
Ac (1.46 ± 0.040 µmol*min-1*mg-1) and pNP Ac (0.039 ± 0.0057 µmol*min-1*mg-1). The
measurable presence of substrate hydrolysis was suitable for further functional characterization
of WssF.
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A) 4-MUB Ac
0.012

Activity (µmol/min)
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B) pNP Ac
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Figure 4.6 Rate of Reaction with Increasing Concentrations of WssF and specific activity with
Acetyl Donors pNP-Ac and 4-MUB-Ac. A) Reaction conditions performed in 8 replicates, which
included 50mM sodium phosphate buffer pH 7, 0.3 - 1.5 µM AiWssF and 2 mM 4-MUB Ac. B) Reaction
conditions performed in quadruplicate included 50mM sodium phosphate buffer pH 7, 0.5 - 4 µM AiWssF
and 2 mM pNP Ac.
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4.3.2 Protein Storage
The use of 10% (v/v) glycerol was assayed as a potential suitable cryo-stabilizing agent
for the long-term storage of purified WssF. Interestingly, the presence of glycerol in standard
esterase assays, with 4-MUB-Ac as substrate, led to increased esterase activity. In fact, the
activity approximately doubled in the presence of 10 % (v/v) glycerol (Figure 4.7) after
accounting for the appropriate controls (ie. assay conditions in the absence of protein, but
presence of glycerol). Protein stocks containing 10 % (v/v) glycerol were always diluted into
reaction buffers so that the glycerol concentration was never higher than 0.5 % (v/v). This
dilution was done so that the presence of glycerol was consistent across all of our assays
(especially the HTS assays where minimization of components like glycerol was required to
prevent unwanted interactions/complications with the compounds assayed). The only exemptions

Specific Activity (µmol/min/mg)

to this was the short and long-term storage assays, which contained 10 % (v/v) glycerol.

4

*

3.5
3
2.5
2
1.5
1
0.5
0
0

0.1

1

10

% (v/v) Glycerol
WssF esterase activity

Figure 4.7 Specific activity of AiWssF in the presence of glycerol. 0.5µM AiWssF tested with 2mM 4MUB-Ac standard esterase assays in increasing concentrations of glycerol. Glycerol increases from 0 %
(v/v) to 10% (v/v) of final assay volume. Assays performed in quadruplicate. p < 0.05 for samples
indicated by the asterisk, which were therefore statistically significant
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Although protein production and purification were optimized, the amount of protein
required to complete both structural and functional characterization was considerable. In order to
improve workflow and minimize protein degradation, storage trials were undertaken to keep
protein stocks viable long enough for increased rounds of analysis. Storage trials of 2mg/mL
protein samples, in enzyme buffer (sonicated and filtered solution of 50mM Sodium Phosphate,
150mM sodium Chloride), were assessed at 4 ˚C, -20 ˚C and, -80 ˚C, with all samples stored
below zero degrees containing 10 % (v/v) glycerol to act as a protectant and assayed over time
for remaining esterase activity (Figure 4.8). Protein samples stored at 4 ˚C saw a significant
decrease in esterase activity after only 3 d relative to the sample assayed on the day of
purification. However, protein stored below freezing retained full activity.
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Figure 4.8 Storage trials of AiWssF. The amount of retained esterase activity (with 4-MUB-Ac as
substrate in standard esterase assays) after storage at the indicated temperatures was used to assess the
storage condition. Samples stored at -20 ˚C and -80 ˚C contained 10 % (v/v) glycerol in the enzyme
buffer, while 4 ˚C was stored in enzyme buffer without glycerol. All trials are calculated relative to an
initial assay performed on the day of purification in the absence of glycerol (day zero = 100 % activity).
Trials consisted of 4 replicates. p < 0.05 for samples indicated by the asterisk, which were therefore
statistically significant.
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Following the success of these short-term (7 day) trials, long-term storage assays were
also undertaken to analyze the longevity of the activity of WssF under these conditions (Figure
4.9). Fresh protein samples were frozen at -80 ˚C with 10 % (v/v) glycerol and storage trials
monitoring over a 38 d period noted that this condition stabilized the activity over the course of
the trial (relative to day zero pre-freezing trials as a reference point). Each day corresponds to a
separate aliquot of enzyme to avoid multiple freeze/thaw cycles of one sample. With long-term
storage of protein sorted, expression and purification of WssF was scaled up and protein stored
for downstream analyses with confidence that the protein was active and stable.
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Figure 4.9 Long term storage trials of AiWssF. The amount of retained esterase activity (using the
standard esterase assay with 4-MUB-Ac as substrate) after storage at the indicated temperatures was used
to assess the storage condition. Samples stored at -80 ˚C contained 10 % (v/v) glycerol in the enzyme.
Trials consisted of 4 replicates.
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4.3.3 Characterization of Esterase Activity
4.3.3.1 Kinetic Analysis

Once the esterase activity of WssF was reliably verified, efforts were made to determine
the kinetic parameters of this reaction. Initial rates were determined using a reaction mixture of
WssF protein with increasing concentrations of pNP-Ac acting as a substrate donor (Figure 4.10,
Table 4.4). The Vmax was determined to be 0.0063µmol/min for AiWssF and 0.0043 µmol/min
for PfWssF, indicating the maximum rate of reaction when all units of WssF are saturated with
substrate. The binding affinity of WssF for pNP-Ac (KM)was determined to be 7.18 ± 2.71 mM
for AiWssF and 2.88 ± 1.38 mM for PfWssF. The turnover rate or kcat for AiWssF was 0.34 ±
0.06 s-1, whereas PfWssF had a kcat of 0.24 ± 0.033 s-1. Finally, the catalytic efficiencies or
kcat/Km values of AiWssF and PfWssF were 47 s-1*M-1 and 83 s-1*M-1, respectively. Thus, under
these conditions, PfWssF is almost twice as catalytically efficient as AiWssF.
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Figure 4.10 Michaelis-Menten Kinetic Curves of WssF Constructs. The assay was performed in
quadruplicate and quantitatively assessed at 405 nm for 30 min with pNP-Ac concentrations ranging from
0-16mM.
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Table 4.4 Kinetic analysis of WssF Enzymes

Construct

Vmax (µmol/min)

KM (mM)

kcat (s-1)

kcat/KM (s-1· M -1)

PfWssF

0.0043

2.88 ± 1.38

0.24 ± 0.033

83

AiWssF

0.0063

7.18 ± 2.71

0.34 ± 0.056

47

* Kinetic parameters were calculated using the Michaelis-Menten program from GraphPad non-linear
regression one-binding site model.

4.3.3.2 pH profile of WssF activity

To further characterize the activity of both AiWssF and PfWssF constructs, a pH profile
was created (Figure 4.11). A buffer system, consisting of MES, phosphate and Tris, facilitated
the assessment of the pH profile with overlapping pH values for a continuous assessment of
activity. MES buffer was used from pH 5.5 - 6.5 and little esterase activity was noted below pH
6.0 and approximately 20 % activity at pH 6.5 for both constructs. From pH 6.5 to 7.5 phosphate
buffers were used, where continued increasing activity was noted from 20 % at pH 6.5 up to
approximately 60 % activity at pH 7.5 for both constructs. Finally, Tris buffer was used to test
pH 7.5 to 9.5 and peak activity was at pH 8.5 (100 %), while above pH 8.5, activity gradually
declined to 80 % by pH 9.5. The bell-shape of the pH curve is indicative of a catalytically
important histidine, since it has two ionizable groups with pKa values of 6 and 9, respectively,
that match this pH profile. While the optimal activity was at pH 8.5, routine assays were still
conducted at pH 7, as this is more representative of the biological buffering in vivo (144).

62

120

Activity (%)

100

80

60
WssF Ai
WssF Pf
40

20

0
5.5

6

6.5

7

7.5

8

8.5

9

9.5

pH
Figure 4.11 pH Profile of WssF Constructs. WssF constructs (4 µM) were assayed with 6 mM pNP-Ac
substrate across various pH conditions using the following compliment of 50 mM buffers: MES from pH
5.5 - 6.5, phosphate from pH 6.5 - 7.5 and, Tris from pH 7.5 - 9.25. The normal distribution may indicate
two ionizable groups on an active site residue. The assays were performed in quadruplicate; molar
absorptivity’s used the activity calculations can be found in appendix B.

4.3.3.3 Common SGNH Hydrolase Inhibitors

Based on the bioinformatic predictions (Section 4.1) the WssF proteins have homology to
the SGNH hydrolase family. As such, common inhibitors for SGNH subfamilies were used to
assess possible functional characterizations (Table 4.5). EDTA, a metal chelator, was added to
WssF reactions in increasing concentrations and at 5 mM (higher than biologically tolerant)
EDTA was unsuccessful at knocking out esterase activity. AiWssF retained 77 % activity while
PfWssF retained almost 60 % activity in the presence of 5 mM EDTA. As such WssF is unlikely
to share a functional pathway with Metalloproteases to achieve esterase reactivity, which are
inhibited by metal chelators, such as, EDTA (145, 146). Next, PMSF was used to determine if

63

WssF esterase activity shared a functional pathway with serine proteases (also includes serine
esterases, lipases and others with a Ser-His-Asp active site). PMSF imitates the characteristics of
a serine protease substrate and binds covalently to the nucleophilic serine within the active site,
causing loss of activity. When biologically toxic levels of PMSF were added to WssF reaction
mixtures, AiWssF still retained 100 % activity and PfWssF retained 80 % activity in the presence
of 5 mM PMSF. As a follow up step, WssF was also tested for inhibition by MSF, which has the
same inhibition mechanism as PMSF, but is a smaller chemical that lacks the bulky phenyl
group. AiWssF still retained 84 % activity and PfWssF retained 60 % activity in the presence of
5 mM MSF. The common inhibitor profile was not conclusive as such other avenues to
characterize the active site were then initiated with respect to mutagenesis of conserved active
site residues (discussed in section 4.3.3) and high-throughput screening of unique inhibitors
(section 4.3.4).
Table 4.5 WssF Common Inhibitor Profile.

Reagent

Residual Activity (%)*
PfWssF

AiWssF

5 mM EDTA

57.9 ± 9.4

77.4 ± 1.5

5 mM PMSF

80.3 ± 5.2

100.0 ± 2.3

5 mM MSF

60.1 ± 1.2

84.2 ± 0.8

* WssF was incubated for 1 h with each listed inhibitor in standard assay conditions prior to the assay
being initiated with the addition of 4 mM pNP-Ac. Assays performed in quadruplicate.
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4.3.4 Characterization of O-acetylation activity
4.3.4.1 WssF specificity for acceptor substrates

With esterase activity confirmed, the ability of WssF to also perform acetyltransfer onto
cellulose needed to be tested in order to support the role of WssF as an O-acetyltransferase. As
an initial indication of cellulose oligomer specificity, standard esterase assays with WssF were
conducted in the presence of cello-acceptors of defined length (ie., cellobiose to cellohexaose)
(Figure 4.12). While PfWssF esterase activity did not deviate beyond the standard error of the
no-acceptor control (Figure 6.13; Donor only), AiWssF esterase activity increased with the
longer cellulose acceptors. AiWssF had approximately 120 and 140 % activity, compared to the
control reaction, for the cellopentaose and cellohexaose reactions, respectively. The cellohexaose
reaction for AiWssF was the only test with a significant value (p < 0.05). These results provide
indirect evidence of substrate acceptor specificity for AiWssF, which is further analyzed directly
in section 4.3.5.
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Figure 4.12 WssF Cellulose Acceptor Profile. Profile of acetate hydrolysis by WssF constructs using
standard esterase assays in the presence of increasing lengths of cellulose-oligomers, 4 µM AiWssF or
PfWssF and 5 mM pNP Ac. Assays performed in quadruplicate. All specific activities are relative to the
no-acceptor (Donor Only) control. p < 0.05 for samples indicated by the asterisk, which were therefore
statistically significant.

Chitin oligomers (analogous to cellulose but containing an N-acetyl group at position 2 of
the sugar ring) were also assayed under the same conditions to determine if WssF acceptor
substrate selectivity was specific for cellulose (Figure 4.13). Increasing lengths of chitooligomers, chitobiose to chitohexaose, were added to both AiWssF and PfWssF reaction mixtures
and assayed under the same conditions as the cello-acceptor. In contrast to the cello-acceptor
trials, none of the chito-acceptor substrates led to increases in activity for either version of WssF.
In fact, there was a slight 10 % decrease in activity for most of the substrates, while chitotetraose
reactions had the only significant (p < 0.05) decrease of approximately 65 % for AiWssF and 75
% for PfWssF relative activity. Thus, these results further corroborate the indirect esterase
activity evidence that AiWssF has specificity for cello-acceptor binding.
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Figure 4.13 WssF Chito-oligomer Acceptor Profile. Profile of acetate hydrolysis by WssF constructs
using standard esterase assays in the presence of increasing lengths of chito-oligomers, 4 µM AiWssF or
PfWssF and 5 mM pNP Ac. All specific activities are relative to the no-acceptor (Donor Only) control.
Assays performed in quadruplicate. p < 0.05 for samples indicated by the asterisk, which were therefore
statistically significant.

4.3.4.2 Thin Layer Chromotography and Mass Spectrometry Assessment of WssF Acceptor Products

Thin layer chromatography (TLC) was initially used to assess acetyltransfer by WssF
onto cellulose oligomers as a direct verification of acetyltransfer, which had previously been
inferred from the esterase assays. After leaving reaction mixtures containing various lengths of
cellulose for 24 h, the cellulose acceptor product was purified with SPE carbograph columns and
analyzed by TLC, with assistance from Dave Sychantha in Anthony Clarke’s lab (University of
Guelph). Investigation through TLC revealed the cellulose oligomers were modified in the
presence of AiWssF (Figure 4.14). As the length of the cellulose acceptor increased, the strength
of a secondary band increased, and the presence of a faint third spot was observed with the
cellopentaose and cellohexaose acceptors. These results indicate successful modification and that
a possible second acetyltransfer event onto these substrates may have also occurred. To confirm
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these TLC results, the cellopentaose sample was analyzed by mass spectrometry (Figure 4.15).
Masses consistent with mono- and di- acetylated cellopentaose as sodium and potassium adducts
(MS in positive ion mode) were detected in the spectra of AiWssF but absent in the control (not
shown).

Figure 4.14 WssF Cellulose Acceptor Analysis by TLC. Assays were performed in 50mM sodium
phosphate buffer (pH 7), 1mM cello-acceptor, 4µM AiWssF, and 6mM pNP-Ac as the acetyl donor for 24
h. Lanes are in pairs for each cello-acceptor length (triose – hexaose), where the (-) denotes the negative
control reaction with no enzyme and (+) denotes the sample of post-reaction purified cello-acceptor that
was treated with AiWssF. The addition of an acetate adduct onto the substrates alters the retention time so
that there is the observable appearance of acetylated product above the control band. These reactions were
purified utilizing SPE carbograph columns and the samples were separated with a mobile phase of ethyl
acetate, water and methanol (6:3:6 v/v) and stained with α-naphthol staining solution (3 % (v/v) w/v α–
naphthol in 25:3:2 methanol, sulfuric acid and water).
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Figure 4.15 TLC and Mass Spectroscopy of Acetylated Cellopentaose. TLC of cellopentaose with
and without AiWssF present (Left panel). ESI Mass Spectrometry of the positive TLC sample to
determine presence of O-acetylation (Right panel). M denotes the mass of cellopentaose (828 g/mol),
while H+, Na+, K+ and Ac denote the addition of a hydrogen (1g/mol), sodium (23 g/mol), potassium (39
g/mol) and/or acetate (42 g/mol) to the cellopentaose, respectively.

Once cellulose acetylation was observed, samples were prepared to create multiple time
courses with cello-acceptors to obtain information regarding the rate of acetyltransfer (Figure
4.16). Reaction mixtures containing either cellobiose or cellopentaose were left to react with the
AiWssF and PfWssF enzymes and were sampled over a 24 h time period. None of the cellobiose
samples analyzed had a secondary band indicating modified cellobiose, despite the fact that
esterase activity (ie. an increase in pNP product) was observed. In contrast, the AiWssF and
cellopentaose containing samples displayed the appearance of a secondary band (Ac-modified
cellopentaose product) after 1 h that increased in intensity over the course of the reaction, while
the unmodified cellopentaose substrate (lower band) decreased in intensity (Figure 4.16; Panel
A). While the results from TLC with PfWssF were not as clear (despite multiple attempts), the
results are consistent with AiWssF, where an increasing intensity of the acetyl-product (noted as
a smeared band above the unmodified reactant) was observed over the course of the experiment.
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A) AiWssF 24 h Time Course

B) PfWssF 24 h Time Course

Figure 4.16 TLC Analysis of 24 h Time Course Reactions of WssF and Cello-acceptors. Assays were
performed in 50mM sodium phosphate buffer (pH 7), 1mM cello-acceptor, 6 mM pNP-Ac as the acetyl
donor and 4µM AiWssF (Panel A) or PfWssF (Panel B). For both Panel A and B, Lanes 1-8 display
reactions with cellobiose and lanes 9-16 display reactions with cellopentaose as acceptor over the sampled
24 h time period (as indicated below the image).
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Following TLC analysis, samples from the reaction mixtures were sent for MS
verification of the acceptor products. For the control reaction mixture, a signal was detected at a
mass of 848.52 m/z, which corresponds with an ammonia adduct of cellopentaose (Figure 4.17;
Panel A). While the AiWssF and PfWssF treated samples (Figure 4.17; Panels B and C
respectively) also had masses consistent with cellopentaose sodium and/or potassium adducts,
they also contained peaks consistent with acetylated polymer. For AiWssF, the spectral profile
reconfirmed the previously analyzed sample (Figure 4.15), where a mass of 893.53 m/z was
detected corresponding to a sodium adduct of acetylated cellopentaose. Weaker mass signals for
the 909.52 m/z potassium adduct of acetylated cellopentaose were also noted (Figure 4.17; Panel
B). For PfWssF treated reactions, the cellopentaose sodium adduct (851.52 m/z) was observed,
but the only other notable peak was the diacetylated cellopentaose potassium adduct (950.58
m/z). Comparison of the AiWssF and PfWssF results reveals profile differences that are
characteristic to each enzyme, where after 24 h all of the detectable product for PfWssF had
undergone two acetyltransfer events, while AiWssF under these conditions had both
monoacetylated products.
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Figure 4.17 MS Analysis of WssF Time Course Assay. Mass spectra of the control sample (Panel A),
AiWssF treated (Panel B) and the PfWssF treated (Panel C) 24 h samples from the time course assays are
depicted. M denotes the mass of cellopentaose (828 g/mol), while H+, Na+, K+, NH4+ and Ac denote the
addition of a hydrogen (1g/mol), sodium (23 g/mol), potassium (39 g/mol), ammonium (18 g/mol) and/or
acetate (42 g/mol) to the cellopentaose, respectively.
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4.3.5 Site Directed Mutants
4.3.5.1 Expression

Based on bioinformatics results (section 4.1), alanine mutants of conserved potential
active site residues (Ser17-His188-Asp191; AiWssF amino acid numbering) were created in
order to verify the role of these residues in catalysis. The mutated proteins were successfully
expressed and purified using the same protocols as the unmutated original AiWssF construct,
albeit at lower yields. For example, yields of 2.7, 2.5 and 1.5 mg of protein/L of culture were
obtained following IMAC purification for the S17A, H188A and D191A AiWssF mutants,
respectively, compared to 3 mg of protein/L of culture for the wild type (WT) enzyme (Figure
4.18). Regardless, there was enough protein to concentrate and use in subsequent activity assays
for each of the constructs.

Figure 4.18 SDS-PAGE Purification of AiWssF and the Active Site Mutants. SDS-PAGE analysis (12
% (v/v)) of AiWssF and active site mutants concentrated eluate following IMAC purification. Lane 1,
molecular-mass markers (kDa); lane 2, Wild Type AiWssF; lane 3, AiWssFS17A; lane 4, AiWssFD188A; lane
5, AiWssFH191A. The expected molecular mass of each of the purified enzymes is 24.6 kDa.
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4.3.5.2 Esterase Activity of Active Site Mutants of AiWssF

Each of the purified mutant proteins were assayed for esterase activity utilizing pNP Ac
or 4-MUB Ac substrates in standard assays and compared to the WT enzyme (Figure 4.19).
Using the unmutated sample as the standard all mutants saw a statistically significant (t test, p <
0.05) reduction in activity for both substrates. When testing with pNP Ac residual activity for the
AiWssFS17A mutant was 57.8 ± 4.7 % whereas the AiWssFD188A and AiWssFH191A mutants each
retained 32.7 ± 1.6 % and 25.5 ± 3.9 % activity respectively. When tested in 4-MUB Ac residual
activity for the AiWssFS17A mutant was 23.3 ± 1.9 % whereas the AiWssFD188A and AiWssFH191A
mutants each retained 13.1 ± 1.8 % and 25.5 ± 4.1 % activity respectively. Residual activity for
the AiWssFH191A mutant was consistent between both substrates whereas AiWssFS17A and
AiWssFD188A had less than half the residual activity with 4-MUB Ac than they did with pNP Ac.
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Figure 4.19 Relative Esterase Activity of the AiWssF Catalytic Triad Mutants. The amount of
retained esterase activity with either 6mM pNP-Ac or 4-MUB-Ac as substrate in standard esterase assays
for the WT enzyme and the S17A, D188A, H191A mutants thereof. Trials consisted of at least 4
replicates. *p < 0.05 for all mutant samples was determined, which were therefore statistically significant.
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4.3.5.3 Thin Layer Chromatography Analysis of Active Site Mutant Reactions

TLC analysis for actetyltransfer of each of the active site mutants was performed using
standard reactions in the presence of cellopentaose (Figure 4.20). As noted before, WT AiWssF
reactions had two distinct bands of similar intensity following 24 h reactions. However, no
acetylated product (i.e. band above the control) was noted for either the S17A or the D181A
mutant, despite the residual esterase activity (pNP product) observed for these mutants (Figure
4.19). For the H191A mutant, a slightly less intense unmodified product band was noted along
with a very faint potential second band; thereby suggesting that some residual acetyltransfer
(despite the low residual esterase activity) may be occurring with this mutant.

Figure 4.20 SDM Cellopentaose TLC. Assays were performed in 50mM sodium phosphate buffer

(pH 7), 1mM cellopentaose-acceptor, 6mM pNP-Ac as the acetyl donor and 4 µM WT AiWssF
(Lane 1), AiWssFS17 (Lane 4), AiWssFD188 (Lane 6) and, AiWssFH191 (Lane 8) for 24 h. Lanes 1,3,5,7
represent negative control reactions, which contained no protein. (as indicated below the image).
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4.3.5.4 Mass Spectrometry Analysis of Active Site Mutant Reactions

To further verify the TLC results with the active site mutants, samples from the reaction
mixtures were sent for MS analysis. As before, the WT AiWssF treated sample contained masses
consistent with unmodified (851.51 and 867.49 m/z) and acetylated (893.53 m/z) cellopentaose
(Figure 4.21; Panel A). Analysis of the each of the active site mutant spectra (Figure 4.21;
Panels B-C) had a mass consistent with the unmodified cellopentaose sodium adduct (around
851 m/z). However, although other masses were noted in the spectra of the S17A and D188A
mutants, none of these corresponded to masses consistent with an acetylated product (or
derivative thereof); thereby indicating that acetyltransfer had not taken place to a degree that was
detectable by MS analysis. For the H191A mutant, a weak signal near background levels
corresponding to a sodium adduct of modified product was noted similar to what was observed
during TLC. These results (together with the esterase reaction results), suggest that the Ser-HisAsp conserved residues of WssF do affect the activity of the enzyme and are part of the catalytic
mechanism for acetyltransfer onto cellulose substrates.
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Figure 4.21 Site Directed Mutant Mass Spectrums. Mass spectra of the AiWssF Wild Type positive
control sample (Panel A), AiWssFS17 treated (Panel B) AiWssFD188 treated (Panel C), and the AiWssFH191
Treated (Panel D) 24 h samples from the time course assays are depicted. M denotes the mass of
cellopentaose (828 g/mol), while H+, Na+, K+, NH4+ and Ac denote the addition of a hydrogen (1g/mol),
sodium (23 g/mol), potassium (39 g/mol), ammonium (18 g/mol) and/or acetate (42 g/mol) to the
cellopentaose, respectively.

4.3.6 High Throughput Screening for WssF Inhibitors
For high throughput screening (HTS), the standard esterase assay was first assessed and
optimized prior to screening. As an initial step, a Zʹ value was determined for the standard
esterase reaction with AiWssF (Figure 4.22). Zʹ is a unitless value that can be used to determine
whether a reaction is amenable to HTS because it provides an indication that there is a great
enough window between the detection of a positive reaction and the background. The assessment
of inhibitors in the HTS screen can then be reliably detected in this window as the decrease in
activity. The following formula was used to calculate Zʹ:
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Formula1:
Zʹ = 1 - (3 * (Standard Deviation of Positive Reaction) + (3 * (Standard Deviation of the Negative
Control) ÷ |(Mean of the Maximum Signal Control - Mean of the Minimum Signal Control)|).

Values for Zʹ range from 0-1, with higher quality data the closer the reaction approaches
1. In the case of WssF, Zʹ values consistently reached or exceeded 0.8 across separate
purification samples, which was higher than the 0.7 that was deemed sufficient for reliable data
collection. The assay was then miniaturized in volume (45 µL) and enzyme concentration (0.75
µM AiWssF) to conserve substrates and enzyme, while maintaining a Zʹ value of 0.8 (Figure
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Figure 4.22 Representative Zʹ 4-MUB-Ac Fluorescence Assay. WssF esterase activity measured
through the fluorescence of 4-MUB as a reaction byproduct. Reaction was performed in a 45 µL reaction
mixture with a final concentration of 0.5 mM 4-MUB-Ac and 5 % (v/v) DMSO. A trial with 20 replicates
used for the Zʹ calculation are depicted here.
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4.3.6.1 HTS at SPARC Biocentre

Once the optimization of the reaction was accomplished, samples of AiWssF were sent to
the SPARC facility at The Hospital for Sick Children (Toronto) for HTS screening. Primary
screening of approximately 64 000 compounds revealed 103 hits with Z scores ≤ -3 (Figure
4.23). To clarify, a Z score of -3 indicated that the activity associated with 103 hits were at least
3 standard deviations reduced compared to the mean activity of the positive control (Figure
4.23; Orange to Green spheres). The 103 hits represent a hit rate of 0.16 %, which is expected
following primary screening.

Figure 4.23 Comparison of % Inhibition vs Z score for Potential Inhibitory Compounds of
AiWssF. Compounds with a Z score at least 3 standard deviations below the positive control (Z score = 0)
are depicted in orange to green circles and were selected for further study. Data from this primary screen
represent single trials with compound at 20 µM.

Secondary screening of the 103 hits was done to repeat the results of the primary screen for these
compounds in triplicate. Potential inhibitors for similar putative acetyltransferases (WssI, PatB
and, OatA) uncovered in parallel screens were also included in the secondary screen of WssF for
a total of 146 compounds. Following secondary screening, 83 compounds were further selected
for dose response testing based on the removal of Pan-Assay Interference Compounds (PAINs)
identified with consultation with Dr. Mark Nitz (University of Toronto). PAINS compounds
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consist of those that have non-specificity in binding, disruptive functional groups and often give
false positives. The remaining 83 promising compounds were found to reach 100 % inhibition
(Figure 4.24) and IC50 values calculated from the curves were 9.49, 11.3, 19.5, 31.6 and 37.4
µM for compounds 1-5, respectively.
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Figure 4.24 Dose Response Curves of the Top 5 Hit Compounds From HTS Screening of AiWssF.
Compounds were chosen based on IC50 values below 100µM. All assays were conducted in triplicate in
47 µL final well volumes with 0.5 µM protein concentration and 0.5 mM 4-MUB-Ac substrate.
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4.3.4.2 Verification of Inhibition at WLU

From the dose response curves, identified compounds with at least 80 % inhibition and an
IC50 value of less than 100 µM, a list of 47 compounds was created to undergo testing for false
positives. All of the tested compounds were found to have quenched the fluorescence activity
within the well condition and were false positive hits. As a result, 18 promising compounds were
instead chosen from the primary and secondary screens for further analysis. All 18 compounds
were subjected to dose response assays and Figure 4.25 depicts the curves from the top 3 hits.
Compound A was found to have an IC50 value of 48.09 µM achieving 70 % inhibition by 100
µM, while compound B had an IC50 value of 43.21 µM and 70 % inhibition by 100 µM. Finally,
compound C was found to have an IC50 value of 71.55 µM achieving 60 % inhibition by 100
µM.
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Figure 4.25 The Top 3 Hit Compounds from the Second Dose Response Assay of AiWssF Inhibitors.
Compounds were chosen based on IC50 values below 100µM. All assays were conducted in triplicate in
47 µL final well volumes with 3 µM protein concentration and 0.5 mM 4-MUB-Ac substrate.

4.4 Structural Characterization of WssF (Objective 3)
4.4.1 Crystallization Trials
In order to fully characterize WssF as an acetyltransferase, purified protein was used to
create protein crystals for structural analysis. Multiple sparse matrix screens, including MCSG 1
through MCSG 4 and a top 96 formulation of conditions, were used in initial crystal trials to
produce protein crystals (a conservative estimate of approximately 480 total conditions were
assayed). After approximately 4 months, four crystal conditions led to the production of protein
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crystals (Summarized in Table 4.6). Two crystal hits were observed from the MCSG-1 screen in
these initial trials (conditions F1 and H10) when 29.11 mg/ml protein in Tris-HCl buffer (pH 7.4
was used and mixed in a 1:1 ratio with the crystal condition (see Table 6.4 for condition
components). Two other hits; one from the MCSG 1 screen (condition B8) and another from the
Top96 screen (condition E2) were created with 15 mg/ml of protein mixed 1:1 with well
conditions (Table 6.4).
Table 4.6 Successful Crystal Conditions. Well conditions F1, G10 and, H10 from the MCSG1 screen
were used with 29 mg/ml protein in Tris-HCl buffer. Well condition B8 from the MCSG1 screen used 15
mg/ml protein in Tris-HCl buffer. Well condition from Top 96 formulations was used with 15 mg/ml
protein in Tris-HCl buffer.
Well Position

Condition

Concentration

F1

0.1 M Bis-Tris:HCl pH 6.5 and, 20 % (w/v) PEG MME 5000

29 mg/mL

H10

0.1 M HEPES:NaOH pH 7.5 and, 25 % (w/v) PEG 3350
0.17 M Sodium Acetate, 0.085 M Tris:HCl pH 8.5 and,
25.5 % (w/v) PEG 4000, 15 %
0.1 M Magnesium Formate and, 15 % (w/v)PEG 3350
25 % (w/v) PEG 3350

29 mg/mL

B8
G10
E2

15 mg/mL
29 mg/mL
15 mg/mL

From the wells that produced crystal hits, images were taken before the crystals were
frozen for data collection. Example images of the successful crystal hits and diffraction patterns
are displayed in Figure 4.26. The crystal formed from the Top 96 formulations had a yellowish
appearance and formed in a wedge like shape on one end, whereas the crystal from well F1
formed in a wide hexagon like shape. Both crystals were subjected to X-ray analysis at the
Canadian Light Source (CLS) and found to have diffraction patterns with a resolution of 2.1Å for
the crystal formed in well E2 and 2.2Å for the crystal formed in well F1 (Data statistics are
summarized in Table 4.7 for the E2 crystal)
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1.55 Å resolution

2.2 Å resolution
Figure 4.26 Crystal Hits and X-Ray Diffraction Patterns from Top Crystal Hits. 15 mg/mL protein
(Top) TOP96-E2: 25 % (w/v) PEG 3350. 29.11 mg/mL protein (Bottom) MCSG1-F1: 0.1M Bis-Tris
(pH6.5); 20 % (w/v) PEG 5000 MME.

4.4.2 Diffraction Data
Single crystals isolated from these drops were assessed to have resolutions of ~ 1.5 - 2 Å
(Table 4.7) following X-ray diffraction analysis at the Canadian Light Source (CLS) and
University of Waterloo. From these crystals, high resolution data sets were collected for
processing. From the two examples shown in Table 4.7 analysis of both crystals (~ 1.5 - 2 Å)
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displayed strong quality indicators for their high-resolution shells. Data processed from the
crystal from the Top 96 condition E2 was found to have strong CC1/2 values close to 1 as the
resolution shells increased (1.57 - 1.54 Å). CC1/2 is a quality measure, which measures the
correlation between random half data sets and has been found to decrease as the resolution of the
data sets increase (147). A signal to noise ratio or I/σI for E2 was found to be 9.99 overall but
decreased slightly to 8.7 at the highest resolution shells. Traditionally, this ratio is used as a
cutoff measure where bins with values ≥ 2 being selected (147). Completeness for the higher
resolution shells was found to be 98.8 %, which reflects how well the high-resolution data covers
the whole structure. A strong redundancy value (number of reflections ÷ number of unique
reflections) was found for E2 at 13.6 for the highest resolution shells. Based on these quality
indicators the E2 data set is a good choice for further processing. In comparison data sets for the
crystal from the MCSG-1 condition G10 (2.05 - 2.00 Å) was found to have a weak I/σI (1.3), and
a lower completeness (62.6 %). G10 was found to have a strong CC1/2 (0.836) value for the
highest resolution shells. Overall E2 displayed stronger quality indicators and as such was the
best candidate for further analysis.
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Table 4.7 Statistics for X-ray Data Collection and Processing of WssF for Two Typical
Datasets*.

Top96_E2 Condition

MCSG1_G10 Condition

Diffraction Source

CMCF beamline 08B1-1

University of Waterloo

Wavelength

0.979

1.540

Temperature

100 K

100 K

Exposure time

10 s

2 min

Number of images
collected

360

360

Oscillation range

1 degree per image

1 degree per image

Space group

Orthorhombic Primitive

Orthorhombic Primitive

a, b, c, (Å)

43.26, 60.08, 77.13

42.38, 59.90, 77.39

α, β, ɣ, (°)

90.0, 90.0, 90.0

90.0, 90.0, 90.0

Resolution range (Å)

47.40-1.54 (1.57-1.54)

25.8-2.00 (2.05-2.00)

Total number of
reflections

436883 (19459)

22530 (763)

Total number of unique
reflections

30220 (1433)

12705 (5260)

Rmeas

0.055 (0.355)

0.059 (0.0.364)

I/σI

9.99 (8.7)

15.8 (1.3)

CC1/2

0.999 (0.983)

0.995 (0.836)

Completeness (%)

99.4 (98.8)

91.36 (62.6)

Redundancy

14.5 (13.6)

1.8 (1.2)

Mosaicity

0.132

1.3

Cell dimensions

* Data in brackets represent the highest resolution shell
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4.4.3 Expansion Trials
Initially, several expansion plates were conducted with the Top 96 E2 condition using
different concentrations of PEG (19 to 31%), pH (5.6 – 8.4) and, protein concentration (15-17
mg/mL and 25-29.5 mg/mL), which included different ratios of stock protein solution to
reservoir buffer in each plate created. Example layouts for expansion plates can be found in
Appendix B. Attempts were made to recreate the successful conditions with incremental
changes in all of the aforementioned variables. An example of a success can be seen in Figure
4.27 where well H2 of the expansion plate contained the Top 96 E2 condition without any
adjusted variable. While expansion crystals have not been sent for X-ray diffraction, they are
being utilized for condition optimization and crystal seeding.

Figure 4.27 Crystal Images from Expansion Trials of WssF. A) A concentration of 15 mg/mL protein
was mixed 1:1 with 25 % (w/v) PEG 3350 from well H2 (Top 96 E2 Condition) of expansion plate shown
in Appendix B (Figure G).
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4.4.4 Molecular Replacement
Molecular replacement (MR) was initially attempted with the WssF data using automated
molecular replacement programs (MRage in Phenix and BALBES, MrBump and MoRDa in
CCP4 online), which scan the existing PDB databases for hits based on sequence identity to
perform MR with the experimental data. Typical outputs from these automated MR trials refined
with Rwork/Rfree values close to 0.5/0.5; thereby indicating that placement of the solution/model in
the electron density is random and cannot be used. As an alternative MR route, the top five
Phyre2 results from the bioinformatics analysis (see Table 4.2) were used as models with the
Phaser programs from the Phenix suite. However, none of these models were good candidates to
pursue, given the poor fit of the model to the calculated electron density (Rwork/Rfree values close
to 0.5/0.5) post refinement. Future experiments will have to focus on generating better
replacement models or pursuing alternate methods to determine the phases and solve the
structure.
4.4.5 Small Angle X-Ray Scattering
In parallel with protein crystallization and X-ray diffraction analysis, attempts were also
made to structurally characterize WssF through SAXS analysis. The best quality SAXS model
data, for both AiWssF and PfWssF were created from the highest concentration samples analyzed
(10 mg/ml). Analysis of SAXS data was conducted using Frameslice to merge the data, followed
by SCATTER to analyze and fit the data patterns. After merging and fitting the data patterns
PRIMUS was used to fit the P(r) function for later processing with online servers (ATSAS and
SIBYLS). The results in Table 4.8 represent the manual data fitting done in SCATTER and
automated online processing completed in ATSAS. The Rg value represents the radius of gyration
of a particle and can be obtained from Guinier fitting both manually or using an auto Rg function
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(129). The Rc value represents the cross-sectional radius, which is used in conjunction with the
Rg value to obtain information about the shape of a particle. In the case of globular proteins both
Rg and Rc values should be similar as the protein is almost as wide and it is long. This was the
case for both AiWssF and PfWssF, with Rg values (30.5 and 25.1) close to their Rc values (18.4
and 16.1), which are predicted (Phyre2) to be globular. Optimization of the SAXS model in
GNOM found an optimal max dimensional score (Dmax) of 50.0 for AiWssF and 53.0 for
PfWssF.
Table 4.8. SAXS Analysis Values from SCATTER and GNOM. Rg and Rc obtained from SCATTER
and Dmax(Å) obtained from GNOM.

Construct
AiWssF
PfWssF

Rg Value

Rc Value

Dmax (Å)

30.5
25.1

18.4
16.1

50.0
53.0

Figure 4.28 is a comparison of the SAXS model of AiWssF, shown in blue, to the Phyre
2 prediction model, shown in red, from Figure 4.1. The SAXS models were manipulated in
PyMOL to overlay the structures with the Phyre2 prediction models using DAMAVER. Both
models share similar generic characteristics of size and globular shape. The alignment of the two
however was represented by a CRYSOL chi square value of 563.8. This value signified that the
differences between the models were not due to random chance.
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A

B

Figure 4.28 AiWssF SAXS and Phyre2 AiWssF Model Comparison Overlays. The Phyre2 prediction
model of AiWssF is shown in red, while the SAXS model is depicted in blue. Panels A and B represent
the same overlayed models rotated 90˚ relative to each other.

In the case of PfWssF the same comparison revealed similar results. Figure 4.29
compared the SAXS model of PfWssF, shown in blue, to the Phyre 2 prediction model, shown in
red, from Figure 4.1. Both models shared similar generic characteristics, such as, size and
globular shape. The alignment of the two however was represented by a CRYSOL chi square
value of 9999.9. This value signified that the differences between the models were not due to
random chance.
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A

B

Figure 4.29 PfWssF SAXS and Phyre2 PfWssF Model Comparison Overlays. The Phyre2 prediction
model of PfWssF is shown in red, while the SAXS model is depicted in blue. Panels A and B represent
the same overlayed models rotated 90˚ relative to each other.

A further comparison was made between the AiWssF SAXS data model and the PDB
structure of AlgX (PDB:4KNC)(69). This comparison revealed that the WssF model was
approximately one quarter the size of the AlgX model (Figure 4.30). When super imposed and
aligned the two models did not share the generic characteristics of shape and size. However, the
WssF model was imposed over the N-terminal SGNH hydrolase-like domain, where WssF
displays the strongest homology. The fact that WssF was not predicted to contain a CBM domain
like AlgX further supported this overlay and fitting orientation. The CRYSOL chi square value
was found to be 712.4. As with the previous comparisons the difference between the models was
not due to random chance.
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B

A

C

Figure 4.30 AiWssF SAXS model and Solved AlgX structure comparison. The SAXS model of
AiWssF is shown in turquoise and white, while the AlgX model (PDB:4knc) is depicted in red, green and,
blue. Panels A and B represent the same overlayed models rotated 90˚ relative to each other. Panel C
represents a surface SAXS model of AiWssF while the cartoon model of AlgX depicted in green
(PDB:4knc), the carbohydrate-binding module is labelled below the N-terminal SGNH hydrolase-like
domain.
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5. Discussion
5.1 Bioinformatics and Prediction models
Biofilms are a common protection mechanism for various bacteria (12, 64). For strains
like A. insuavis and P. fluorescens acetylated cellulose comprises the primary structure of the
biofilm. The wss operon is responsible for the synthesis and modification of the acetylated
cellulose polymer. After synthesis, proteins WssG,H,I,F are responsible for the O-acetylation of
cellulose before the polymer is exported from the periplasm (28). Based on sequence prediction
(Figure 5.1), WssF is likely an acetyltransferase, utilizing a SGNH hydrolase like domain (148).
In order to determine the best way to investigate the function of WssF, the amino acid sequences
of the WssF constructs were analyzed using bioinformatic techniques (Table 5.1). Sequence
analysis from BLASTp predicted a potential catalytic triad formed by residues 17 (Serine), 188
(Aspartic acid) and, 191 (Histidine), which are characteristic of SGNH hydrolases. Furthermore
residues 17 (Serine), 69 (Glycine) and, 103 (Threonine) are predicted to form an oxyanion hole
for stabilization of tetrahedral intermediates that form during SGNH hydrolase reactions (143).
Together these predicted residues may form an active site for WssF acetyltransferase function.
Were these predictions to be correct, it would support the hypothesis that WssF functions as an
acetyltransferase during polymer modification.
As an acetyltransferase, WssF would first need to remove acetate from an acetyl donor.
Secondly, WssF would modify the cellulose polymer through O-acetylation in order to complete
its function as an acetyltransferase. To achieve O-acetylation, WssF is most likely utilizing a
double displacement reaction, as seen with peptidoglycan O-acetyltransferase B (PatB) (Figure
5.1), a protein with similar functionality (143). The double displacement reaction occurs in three
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stages; 1) nucleophilic attack of the donor, 2) acid base catalysis of the acceptor and 3)
nucleophilic attack of the enzyme substrate complex.

Figure 5.1. Proposed catalytic mechanism of PG O-acetyltransferases. The mechanism is presented
with pNP-Ac as the acetyl donor, but in vivo presumably acetyl-PatA serves this function. R1 is either a
hydroxyl group or a β-1,4 linked sugar; R2 is either a hydroxyl group of chito-oligosaccharides or a lactylpeptide moiety of muramoyl-peptides in PG. The nitrophenolate ion is depicted in yellow to signify its
detection at 405nm. Taken from (143)

To further test the predictions, sequence alignments were done to find potential
homologues. This sequence alignment produced only low sequence identity matches, so only
weak predictions could be made for how WssF folds (Figures 4.2). However, the catalytic triad
and oxyanion hole were found to be an exception. Most of the top 50 homologous proteins were
some form of hydrolase, many of which were from the SGNH family. There was strong
sequence coverage and confidence for the predicted active site. Hypothetical tertiary structure
models predicted that low to moderately conserved residues form an // structure that is

95

common for members of the SGNH family (149). However, the A.insuavis construct formed a
less common 4 parallel stranded  sheet compared to the common 5 parallel strands in the P.
fluorescens construct. Mapping conservation scores onto the hypothetical structures reinforced
the predictions that the active site was formed by a catalytic triad and oxyanion hole based on
sequence alignment. Conservation scores for the amino acid sites closest to the predicted
catalytic triad were the highest (142). High conservation scores indicated that those amino acid
sites had the highest consistency among homologs. For an enzyme to retain its function and
therefore usefulness the core catalytic residues must be retained. Empirical evidence of the
functional and structural characteristics of WssF were required to confirm these predictions.

5.2 Profile of Optimal Protein Expression and Purification (Objective 1)
5.2.1 Expression Profile of WssF
To confidently work with WssF, stocks of pure protein were required. In order to
facilitate this necessity, months were spent testing optimal conditions for the expression and
purification of WssF. Previous work and assistance from Mr. Adam Miller and Ms. Emily
Wilson (former Weadge lab members) allowed us to determine the optimal expression conditions
for WssF. Various temperatures and lengths of expression were used to determine the largest
yields of protein. For example, temperatures of 16 - 18 ºC were attempted as similar proteins in
our lab, such as, WssI, have optimal expression patterns in this range. In parallel, expression at
37 ºC, the optimal growth temperature for E. coli was attempted. Choosing a temperature similar
to that of a potential internal host may mimic the conditions that proteins like WssF are naturally
induced at. However, neither expression produced sufficient protein yields, which led to further
expression attempts at 30 ºC, the preferred growth temperature range of P. fluorescens and A.
insuavis, as observed in lab (150). Strong bands on an SDS-PAGE gel were noted as
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considerable yields when expressed at 30 ºC (Figure 4.3). Following this result, a longer
expression window was attempted, and these expression trials revealed 16 - 18 h expression led
to the best yields. Once a strong profile for expression was established trials for optimal
purification were explored.
5.2.2 Purification Profile of WssF
To purify WssF, increasing imidazole concentrations were tested on an IMAC column to
hone in on precise elution conditions. Analysis of imidazole gradient revealed that one wash
without imidazole would remove some contaminates while a second with 50mM was the limit
for removing additional contaminates without substantial protein elution (Figure 4.4). The purer
the eluted enzyme, the less likely secondary purification would be required, which would remove
an entire day from the purification process. This reduction was important as an additional day
was found to reduce esterase activity to 60 % of the previous day. Once sufficiently pure protein
was produced for functional characterization, trials for storage of protein stocks began
immediately. Optimal storage would allow for protein samples to be shipped for testing, such as,
for HTS to minimize the need for repeated shipments and purifications. Successful storage trials
at -80 ºC in 10 % (v/v) glycerol facilitated long-term storage greater than 35 days (Figure 4.9).
Concerns were raised when the presence of 10 % (v/v) glycerol led to a 2-fold increase in
activity (Figure 4.7). While the presence of glycerol may be stabilizing the protein in solution,
its presence complicated HTS and the solubility of the compound screening. Analysis of the
trials revealed that after dilution of protein stocks into final well conditions the final
concentration was below the 1 % threshold for increased activity. Due to the chemical properties
of the hydroxyl groups on glycerol it is possible that it may act as a better acceptor than water. In
the case of the DltD enzyme a D-Ala- DltD acyl intermediate undergoes nucleophilic attack by
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the 2-hydroxyl group of a glycerol attached to a lipoteichoic acid (LTA), which regenerates the
enzyme producing D-Ala-LTA (74). The ability of glycerol to increase the esterase activity of
WssF was not investigated further, but this represents an area of future functional
characterization work.
For structural characterization purity of the sample was paramount, so secondary
purification was required for these analyses. SEC produced a purer product but reduced the
overall yield (Figure 4.4). As a result, greater volumes of culture were expressed and purified
when attempting to structurally characterize AiWssF. Given the low yields from the tandem
purifications, the amount of protein needed to create each crystal screen (96 wells) would
generally take double the amount of time as a single step purification. While this created a
bottleneck in work flow, successful crystal hits were generated (Figure 4.26).
After optimal expression and purification conditions were determined, final protein yields
of 3 mg/mL were typical from 1 L of culture. Protein yields after SEC varied from 2 mg/mL
from 1 L of culture resulting in an almost 30 % loss. Overall Objective 1 was a success as
sufficient yields of pure protein was obtained to work on functional (Objective 2) and structural
characterization (Objective 3) simultaneously. Newer expressions with Rosetta cell lines were
found to have 3 - 5 mg/mL from 1 L of culture and increased purity (Figure 4.5). Future work on
N-terminal constructs and Rosetta cell lines could improve yields for further structural and
inhibitor studies.
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5.3 Functional Characterization of WssF (Objective 2)
5.3.1 Esterase Characterization of WssF
Characterizing the function of WssF was directed by the predictions made during
bioinformatic analysis. If the hypothetical active site functions via a double displacement
reaction, then there were two reactions that had to be assessed separately. Testing for esterase
activity in the presence of a donor was the best place to start. Analysis of the profiles for both
constructs revealed that increasing the concentration of protein within a reaction led to a
concomitant increase in esterase product that was a linear relationship; thereby confirming
enzyme dependent activity (Figure 4.6). Specific activity values for both WssF constructs were
comparable to AlgX (0.0068 ± 0.00057 µmol min-1 Mg-1) and PatB (0.51 ± 0.01 µmol*min1

*mg-1) acetyltransferase enzymes found in the literature (69, 151). As AlgX is one of the closest

homologs to WssF and an acetyltransferase that also works on an exopolysaccharide polymer, it
is not surprising the rates are comparable. In order to test the reliability of measuring esterase
activity of WssF Zʹ values were determined (Figure 4.22). Measuring the average values for
both the positive and control samples along with their corresponding standard deviations allowed
for confidence that enzyme derived esterase activity was being measured. Zʹ values were
consistently higher than 0.7 indicating that the negative control is significantly different from the
positive reaction. The esterase was also used to determine kinetic parameters for this reaction
(Table 4.10). From the kinetic study AiWssF was noted to have a higher maximum velocity than
PfWssF (Vmax of 0.0063 and 0.0043 µmol/min, respectively). However, PfWssF had a faster
turnover rate (kcat of 0.34±0.056 *s-1 vs. 0.24±0.033 *s-1) and lower KM (7.18±2.71 mM vs.
2.88±1.38 mM) and therefore a better catalytic efficiency (kcat/KM of 47 s-1*M-1 vs. 83 s-1*M-1).
In comparison to the literature, WssF has a kcat/KM comparable to AlgX both of which are only 3
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fold different from PatB when reacting with the pNP acetyl donor analog (70, 151). The results
of the kinetic studies were important as they revealed WssF was capable of efficiently catalyzing
esterase activity. As previously mentioned, this hydrolysis would be the vital first step for any
acetyltransferase reaction.
Further characterization of WssF esterase activity revealed the likelihood of an important
histidine within the esterase reaction. Analysis of the pH profile (Figure 4.11) from pH 5.5-9.5
revealed esterase activity, for both constructs, that follows the ionization pattern of an
imidazolium ring located on a histidine residue (pKa values of 9.44 and 6.04). A normal or “bell
shaped” distribution indicates that protonation of the first nitrogen begins around pH 6.5 where
esterase activity began to increase. Activity dropped at pH levels higher than 8.5, which is
consistent with deprotonation of the second amino group of the histidine side chain residue. As
the second nitrogen becomes fully deprotonated the structure loses the ability to shift its electron
density, a vital step when priming the serine residue for catalysis. Based on the predicted
catalytic triad, the pH profile is indicative that the conserved H191 is likely responsible for
activating the S17 nucleophile between the pH values of 6.5 and 9. In the case of other esterases,
like PatB, the same profile of deprotonation affected function of the catalytic triad (143, 148).
While pH 8.5 was determined to be the pH where optimal esterase activity occurred, it does not
take into account the biological relevance of the pH within the periplasm where WssF is
predicted to be located (pH 5.5 - 7.5) (144). Although this would indicate that the enzyme is
functioning below peak efficiency in the biological system, this may not matter as there may be
other rate limiting steps or the conditions may allow the rate of activity for WssF to match that of
the rest of cellulose synthesis. As a result of these physiological conditions, a pH 7 sodium
phosphate buffer was chosen when maintaining WssF esterase activity for the routine assays.
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5.3.2 Common inhibitor Profile
Among the esterase/hydrolase family there are many enzymes that function with different
mechanisms. An easy way to test for functional differences is through the creation of an inhibitor
profile (Table 4.5). Common inhibitors for other hydrolases, such as, EDTA, PMSF and, MSF
were unsuccessful at removing the esterase functionality of WssF even at biologically fatal
concentrations. The retention of substantial esterase activity in the presence of EDTA provides
support that WssF is not a metalloenzyme. Catalytic dependence on the presence of metals, such
as, cobalt or magnesium, would have been disrupted when the EDTA metal chelator was
introduced (152). However, the retention of activity in the presence of PMSF also suggested that
a nucleophilic serine is not part of the reaction mechanism, as noted with serine proteases. Serine
proteases utilize the same catalytic triad serine, histidine, and, aspartic acid predicted in WssF.
Instead of transferring substrate molecules serine proteases bind and cleave peptides. PMSF
inhibits serine proteases through sulfonylation of the hyperactive serine; thereby blocking the
nucleophilic attack of the substrate (153). It is possible that the selective conditions of the active
site for a cellulose polymer prevent the large hydrophobic ring structure of PMSF from binding
to the active pocket. However, the use of MSF inhibitor, which is smaller than PMSF, did not
lead to complete inhibition. PatB another O-acetyltransferase and Axe1 an acetyl xylan esterase
also retained activity in the presence of PMSF while utilizing a catalytically active serine (143,
154). This provides evidence that WssF may have a similar active site that does use a
nucleophilic serine but occludes these compounds by some unknown property. Additionally,
there have been some unconventional serine proteases, which do not exhibit inhibition by PMSF
(143, 155).
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5.3.3 WssF Acceptor Specificity Profile
WssF was shown to exhibit esterase activity, a requirement for any acetyltransferase
enzyme reaction. However, esterase activity alone was not enough to prove WssF was capable of
catalyzing acetyltransferase activity. Thus, activity profiles in the presence of potential cellulose
acceptors were used to test for the specificity of WssF (Figures 4.12). Reactions with increasing
lengths of cellulose oligomers produced increased esterase activity for AiWssF in the presence of
penta and hexamer polymers. Increased activity may be the result of selective conditions present
within the active pocket of AiWssF. Without cellulose, the esterase reaction relies on water to
remove the acetyl group to regenerate the active site. With the presence of a preferred acceptor,
instead of water, the activity was accelerated. The same increase was not seen for the PfWssF
construct, which suggests that there are subtle active site differences dependent on organismal
background. The specificity of AiWssF for cellulose oligomers was further confirmed when no
changes in esterase activity were noted in the presence of a chito-oligomer acceptor instead of
cello-oligomer (Figure 4.13). Although structurally similar, the presence of the N-acetyl group
appears to be enough to block binding of chito polymers. While the effect of cello-oligomers on
esterase function is promising in the characterization of WssF as a cellulose acetyltransferase,
there is still the possibility that the transferase reaction did not ensue after acetate release from
the acetyl-donor.
5.3.4 Thin Layer Chromatography and Mass Spectrometry
To confirm the ability of WssF to act as an acetyltransferase, TLC was used to analyze
reaction products. Analysis of the TLC experiments with increasing lengths of cellulose
oligomers revealed secondary bands consistent with modified cellulose (Figure 4.14). Longer
lengths of cellulose more closely represent the natural cellulose polymer that undergoes O-
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acetylation, whereas smaller cellulose oligomers may assume multiple orientations within the
active site and interfere with proper binding. As the samples approach more biologically relevant
acceptor lengths, the polymer may only assume a few orientations, and this may lead to more
productive binding where activity ensues. Mass spectrometry (Figure 4.15) was used to confirm
the secondary bands on the TLC plate were in fact acetylated cellulose. Analysis of the
cellopentaose samples revealed that O-acetylated cellopentaose was present within the samples
and that some polymers were O-acetylated twice. A follow up time course analysis (Figure 4.16)
displayed acetylated cellopentaose in as little as 1 h and then increasing intensity over the course
of the reaction. Mass spectrometry (Figure 4.17) again confirmed the TLC results and analysis
of the MS spectra revealed acetylation profile differences between the enzymes from different
organismal backgrounds. These results parallel the differences observed with the esterase assays
in the presence of acceptor mentioned earlier. Under the conditions tested, mono-acetylated
product from the AiWssF reactions appeared as discrete bands on the TLC and could be detected
by MS easily. In contrast, PfWssF reactions analyzed by TLC had a smeared profile and analysis
of the MS results noted the presence of a predominant mass of di-acetylated product and little to
none of the mono-acetylated product. In retrospect, a lot of effort was spent attempting to
improve the smeared bands on the PfWssF TLC plated reactions, however, the smear may
represent di-acetylated products that do not have a uniform acetylation profile and are therefore
not easily resolved by TLC. To clarify, the cellopentaose consists of 5 sugar units with at least
three positions per sugar unit (C2, C3 or C6 for all sugars and also C4 or C1 for the terminal
sugars) that can potentially be modified by WssF. Future studies will focus on using NMR
analysis of both AiWssF and PfWssF reaction products to elucidate the stoichiometry and
regioselectivity of the acetyl modifications. However, even in the absence of this data, the

103

current TLC and MS results verify for the first time that WssF is a cellulose acetyltransferase and
to the best of our knowledge, it is the first cellulose acetyltransferase to be functionally
characterized.
After TLC and Mass spectrometry some questions remained about whether the in vitro
conditions of the tests represent the in vivo conditions found within the periplasm of the cell.
Within the assays the reaction was occurring without the removal of final product from the
reaction mixture. Increasing the final concentration of the product should decrease the rate of
reaction as the system reaches equilibrium. Within the periplasm this is not the case as any
modified cellulose is cleaved and exported. So, while the reaction conditions within the
periplasm are not isolated from external factors, the reaction is continually favouring the forward
direction. In the case of kinetic testing these concerns are overcome by measuring initial rates
that removes the complication of increasing product concentrations. In contrast, the TLC and
Mass spectrometry analyses were testing for the presence or absence of modified cellulose, not
specifically the rate of reaction. Future studies may aim at determining the kinetic parameters of
the transferase reaction, but they were beyond the scope (and cost) of this thesis. Therefore,
while not a perfect representation of the biological scenario, we are still confident that our tests
approximate the function of WssF within the Wss biosynthetic apparatus.
5.3.5 Active Site Mutant Profile of AiWssF
Following verification of WssF as an acetyltransferase, experiments were then conducted
to understand the mechanism of modifying the cellulose polymer. Specifically, site direct alanine
mutants (Figure 4.18) of the predicted catalytic triad were created and profiled to explore their
role in catalysis similar to what has been accomplished for other homologous acetyltransferase
enzymes (70, 143, 156). Determining successful site directed mutagenesis conditions was
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difficult as two sets of primers were developed and only AiWssF produced successful mutants.
Mutant yield and purity were issues as AiWssFD188A was only 50 % pure and had yields less than
half the WT AiWssF sample. Despite the low yields, specific activity assays were still able to be
conducted. While individual alanine mutants of the catalytic triad residues did not completely
abolish activity, the residual activity was lower than the complimentary inhibitor profiles that
targeted the nucleophilic serine (ie. PMSF and MSF trials) (Figures 4.19 and Table 4.5).
Interestingly, mutation of serine had a smaller effect on esterase activity than histidine, when
using pNP-AC as substrate (Figure 4.19). This was surprising, as the loss of the catalytic serine
should have hypothetically blocked the nucleophilic attack on the donor. With respect to the
histidine, our pH profile analysis indicated the importance of this residue in catalysis. The
dramatic loss in activity with this histidine mutant was thus expected, since the histidine can no
longer participate in the proton relay that would render the serine nucleophilic. As an alternative
substrate, each mutant was also assessed with 4-MUB Ac (Figure 4.19) as the acetyl donor.
With this substrate, the residual esterase activity is reduced compared to the parallel pNPAc
reactions. Even the unusually high activity retained by the Serine mutant with pNPAc is far
lower with 4MUB-Ac. This difference may be explained by the fact that pNPAc has been noted
to have non-specific hydrolysis occur in other in vitro esterase assays (157) due to the fact that
the pNP is a good leaving group. While 4-MUB-Ac was a better substrate for these analyses,
there was still residual esterase activity with each of the catalytic mutants. While puzzling,
similar results were noted with the homologous AlgJ and AlgX enzymes from the alginate
system and subsequent structural studies verified that these were in fact the catalytic residues for
these proteins (70). In the absence of a structure of WssF, we elected to verify the role of these
catalytic mutants by also assessing their ability to perform acetyl transfer onto cello-acceptors
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(Figure 4.20 and 4.21). In contrast to our WT AiWssF treated samples, no acetylated cellulose
product was detected by MS for the catalytic triad mutants. This loss of transferase activity is
important, as it verifies the critical nature of the three proposed active site residues to polymer
modification.
5.3.6 Mechanism Prediction
The functional characterization of has provided concrete evidence that WssF, is a
cellulose acetyltransferase. To achieve polymer modification WssF most likely utilizes a double
displacement reaction similar to other O acetyltransferases, such as, PatB, OatA, AlgJ, AlgX
and others (Figure 5.1) (70, 143). A double displacement reaction (Figure 5.2) occurs in three
stages; 1) nucleophilic attack of the donor, 2) acid-base catalysis of the acceptor and finally 3)
nucleophilic attack of the enzyme substrate complex. We predict that WssF follows a similar
reaction mechanism. For the reaction to proceed the carboxyl group of D188 must form a salt
bridge with the imidazolium ring of H191. As a result of this bridge, the electron density shifts
allowing the second amide to remove the proton from S17; thereby priming it for nucleophilic
attack of the donor. After priming S17, the newly formed alkoxide reacts with the carbonyl
carbon of the acetate donor forming a tetrahedral intermediate state. The previously predicted
oxyanion hole stabilizes the intermediate state before it decays into release of the donor
molecule. When the donor molecule leaves it acquires the proton originally from the S17, which
is bonded to H191, completing the first stage of the reaction. For the next stage, acid base
catalysis, H191 once more removes a proton only this time from a hydroxy group located on the
cellulose polymer. Now the alkoxide group on the acceptor repeats the process of the first stage,
nucleophilic attack, to form a second tetrahedral intermediate. Once more the oxyanion hole
stabilizes the intermediate before it either decays back into the enzyme substrate complex or
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releases the acetylated cellulose polymer. After release of the modified cellulose polymer the
predicted active site is once more primed for further reactions. Exporting the modified polymer
reduces the concentration of product unbalancing the reaction. This exportation continually
disrupts equilibrium favouring the reaction to move forward toward product.

Figure 5.2 Hypothetical WssF reaction mechanism. The mechanism is presented with pNP Ac as the
acetyl donor, representing the reaction in vitro. R1 and R2 represent the β1-4 linkages of the cellulose
acceptor. G69, T103 and, a hydrogen from S17 are depicted as the oxyanion hole that stabilize the

tetrahedral intermediates forming during the acetyltransferase reaction. D188 is depicted forming
a salt bridge with H191.

5.3.7 High Throughput Screening Inhibitor Profile
Based on functional profiling and common inhibitor trails (Table 4.5 and Figure 4.22)
the WssF protein likely utilizes its esterase activity to serve as a critical acetyltransferase within
the cellulose synthase complex. Therefore, after characterizing the esterase activity of WssF HTS
was conducted on AiWssF samples in hopes of determining potential inhibitors (Figure 4.23).
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HTS was done with the hopes of identifying compounds capable of blocking the esterase activity
of WssF, which would subsequently arrest the acetyltransferase activity of the protein. Stopping
the acetate modification of cellulose would affect the formation and architecture of the biofilm
because without O-acetylation the biofilm will suffer from increased susceptibility to external
pressures or may not be able to attach and proliferate to target surfaces in the same manner (158).
As previously mentioned, optimized storage conditions were a priority if HTS was to
succeed. Under refrigerated conditions, 4 ˚C, WssF activity was not retained long enough for
accumulation or transport of enzyme stocks. Storage at -80 ˚C in 10 % (v/v) glycerol allowed for
strong Zʹ values, > 0.7, after a month of storage. Successful long-term storage conditions allowed
for confidence in the hit results from Figure 4.23. The HTS screening process also served to test
the esterase activity of WssF for the reliability of measured activity. As previously mentioned Zʹ
values (Figure 4.22) were determined during the initial trials, which revealed that WssF esterase
activity was consistently higher than negative controls. With confidence that false positives
would not result from measuring WssF esterase activity compound screening could begin.
Promising compounds were selected for based on low IC50 values during HTS (Figure
4.24), however, analysis of the data from subsequent fluorescence quenching trials found these
compounds to be unsuitable as their inhibition was the result of false positives. These false
positives were the result of the compounds reducing the fluorescence of the product and not
inhibition of esterase activity. Without any compounds from the initial quenching assay verified,
18 promising compounds from the primary and hit confirmation screens were selected for further
analysis and these were found to not quench the fluorescence of the product.
From the top hit compounds, compounds A, B and, C were successfully assessed for IC50
values at Laurier by Adam DeReuchie-Tan (Figure 4.25). Initial testing with dose response
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curves for these compounds determined IC50 values of 48 – 71 µM. Further testing with pNP-Ac
and live cell assays are required to confirm the viability of these compounds as suitable
inhibitors of biofilm formation/attachment.
Future inhibitor trials will attempt to find the greatest decrease in the esterase activity of
WssF with the lowest concentration of inhibitor possible. Both these factors will be important
when attempting to solve the problem of bioavailability. The ability to deliver the smallest
effective dose of inhibitor to affected tissues will help to prevent reaching TDLO (Toxic Dose
Low) concentrations. TDLO are the lowest dosages per unit body weight that produce signs of
toxicity (159). As with any drug treatment preventing toxic side effects are paramount to health
and safety. Starting with compounds that are highly potent and easily modifiable will help with
achieving effective bioavailability within the TDLO limitations.
5.3.8 Summary
Overall Objective 2 was accomplished due to the successful characterization of WssF as
an acetyltransferase. Hypothesized to function through a double displacement reaction, the
esterase activity of WssF was profiled through kinetic inhibitors and catalytic mutant assays.
WssF was found to have strong esterase activity comparable to similar acetyltransferase enzymes
(70, 143). Second, transfer activity was observed through the use of TLC and MS. Modified
cellulose polymers were only observed in the presence of WssF. Secondary assays with chitooligomers and the catalytic mutants verified that acetyl transfer is specific for cellulose and that
the mechanism is consistent with a double displacement reaction that is typical of homologous
enzymes (70, 143). Finally, the successful functional characterization of WssF allowed the
initial steps of inhibitor screening to begin through HTS, which will involve future verification
trials of biological efficacy.
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Further characterization of WssF is possible through the creation of PfWssF mutants and
further site directed mutagenesis of the hypothetical oxyanion hole. Also, triple mutant genes
would allow for further characterization of the predicted catalytic triad. In addition, WssF could
be tested with more physiologically accurate donors, such as, acetyl-CoA or assessed against
other Wss enzymes. Expanding the functional studies of WssF will strengthen the role of WssF
as an acetyltranferase within the Wss cellulose synthase complex.

5.4 Structural Characterization of WssF (Objective 3)
5.4.1 AiWssF Crystallization and Diffraction
Successful structural characterization of the protein WssF would confirm or correct the
predictions made based on sequence analysis. Efforts to crystalize were met with success, as
diffraction patterns with good resolution were produced (Figure 4.27). Quality indicators, such
as, CC1/2, reported the data to be of high quality for the trimmed high-resolution shells. CC1/2
measured the Pearson correlation coefficient by randomly splitting the unmerged data into halves
and comparing the two data sets (160). Values below 0.3 were considered undesirable or
insignificant correlations. Values for the successful diffraction patterns were significantly above
0.3, reaching 0.9 for the trimmed high-resolution shell. However, good diffraction data (Table
4.7) is not sufficient to solve the crystal structure, as the phase of the diffracted X-rays remains
unknown. The issue known as the phase problem, stems from only the intensity of the collected
X-ray being known (161). No information was measured related to where the collected X-ray
was in its waveform, also known as the phase. With a strong diffraction pattern, the next logical
step was to utilize molecular replacement to aid in determination of the phases.

110

5.4.2 Molecular Replacement
Molecular replacement relies on the solved structure of a homologue to generate
assumptions that can be used to solve the phase of the unknown structure (162). This technique
produces bias as it assumes that the unknown structure folds the same as the homologue based on
sequence data alone. It is possible that, through chaperones or environmental conditions at the
time of folding, the protein may not fold in the assumed pattern when solving the structure.
Although not perfect, molecular replacement does aid in solving structures when no other
technique is presently viable. However, as previously stated, WssF homologues have low
sequence identity and this is likely why molecular replacement trials were met with no success.
Without a solved structure to compare against there is no way to determine the missing phase
information without further X-ray diffraction. One avenue that will be pursued is the use of
heavy atom derivatives or selenomethione incorporation into the crystals to aid with solving the
phases.
5.4.4 Small Angle X-Ray Scattering
Without a solved structure, complete structural characterization was not possible. Data
collected from SAXS however was used to confirm some basic structural characteristics. SAXS
measures density differences within the protein samples (129). This data is then used to create a
representative space-filled model of the structure of WssF. These models would normally then be
used to compare against solved structures. However, without a solved structure the models were
instead compared against the predictive models (Figures 4.28 and 4.29) created during the
bioinformatic analysis (namely Phyre2 outputs). When overlaid onto each other the models do
not line up perfectly and the high chi square values indicated the models did not fit well, as the
chi square value is commonly referred to as a measure of fit (163). The lower the value the
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higher the likelihood the difference within the compared values are random and therefore
significant. With both values significantly higher than the ideal value of one, the models matched
poorly. This mismatching was most likely due to the creation of the predicted model from weak
homologues with variable levels of residue conservation. To compound the problem further, the
globular nature of the WssF proteins lowered the confidence of the SAXS models. Quality
scoring around 65 % in the dimension of fit was observed, which indicated the level of
agreement between the generated model and the curve that was analyzed. Although the models
did not provide a clear pocket or any distinctive structural characteristics, they did further
support the globular nature of the bioinformatics models, previously generated. Based on the
SAXS models the overall size and globular shape of the WssF constructs roughly matched that
of the predicted models despite sequence identity and overall size differences. For example,
comparison between the SAXS data and a solved structure of AlgX (Figure 6.30) revealed that
WssF was one quarter the size AlgX. This was expected as the molecular mass of WssF
(24.5kDa) is roughly one quarter that of the reported molecular mass of AlgX (102kDa) due to
the fact that AlgX has an appended carbohydrate binding module and some extended -strand
regions (69).
Interestingly, the max dimensional values (Rmax) of the SAXS models were 50 and 53.
These values correspond within reason to the cell dimension values for the asymmetric unit of
the diffracted crystals (between 42 and 77). While these data are not definitive, they do support
each other in the structural elucidation of WssF and the predictive bioinformatics models.
5.4.5 Summary
Significant progress has been made towards accomplishing Objective 3, as high-quality
diffraction data sets have been collected for AiWssF, but the phase information still has to be
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determined. After attempts at multiple solutions for the phase problem with molecular
replacement were unfruitful, selenomethionine trials will be undertaken instead. Structural
analysis of WssF was also achieved through the use of SAXS. Although SAXS provided more
generic structural data than the previously attempted characterization techniques it was
consistent with the predictive models generated as a globular monomeric protein. The generic
parameters of WssF, such as, size and general shape match similar acetyltransferases endorsing
the hypothetical models.
5.4.6 Future Directions
As part of the next steps to solving the structure of WssF, crystal trials will be made with
selenomethionine substitution of the six naturally occurring methionine residues within the
sequence of WssF. Substituting selenomethionine into the proteins structure allows for
Multiwavelength Anomalous Diffraction (MAD), which is commonly used when solving the
phase problem (139, 164). MAD relies on a protein to have at least 1 methionine residue per 75100 amino acids and the sequence of WssF falls well within this limitation. Integration of
selenomethionine residues should not significantly alter the protein structure. Once a
selenomethionine crystal is obtained, structural characterization through MAD should be
possible. If MAD techniques provide a high-resolution diffraction pattern, then incorporation of
the previous diffraction patterns can be used to finally solve for the structure of AiWssF.
In the future, efforts to crystalize and diffract the PfWssF construct will need to be
accomplished, which will strengthen the structural characterization already completed for
AiWssF. Based on functional complementarity and sequence conservation, we predict that the
role of the active residues in the overall mechanism will be confirmed. The overall structure of
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WssF, will likely follow the common trends observed for similar EPS acetyltransferases and
their homologous SGNH hydrolase motifs.

6. Conclusion
The focus of this research was defining the function of WssF as a putative
acetyltransferase. To achieve this goal, WssF was characterized both functionally and
structurally. Work was broken down into three objectives, the first objective was profiles of
predicted structure and function, which were created along with the development of optimal
expression and purification conditions to inform how best to elucidate WssF in the last two
objectives. The second objective was functional characterization of WssF as an acetyltransferase,
which was achieved through various tests and analysis. Fluorescence and colourimetry
spectrophotometry where used to access and profile the ability of WssF to catalyze esterase
reactions. Following this, TLC and Mass spectrometry were used to assess and profile the ability
of WssF to modify cellulose in the presence of an acetate donor. This data was then used to
inform HTS screening and inhibitor assays in the hopes of identifying potential inhibitory
compounds for future study. The third objective was structural characterization through X-ray
diffraction and SAXS. Success in the production of diffraction quality crystals overcame this
bottleneck in the research. However, efforts are still underway to solve the structure of WssF
through selenomethionine replacement followed by MAD/SAD techniques. SAXS along with
the functional characterization successfully endorsed our predicted model. Overall the first two
objectives were completed successfully with the third providing significant insight and a clear
path for the full characterization of WssF as an acetyltransferase within cellulose biofilm
forming bacteria.
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The benefits of understanding how to control biofilm development are broad, ranging
from healthcare to agriculture (2, 158). As mentioned, healthcare would benefit directly from
being able to inhibit biofilm synthesis or remove preexisting infections. Advances in antibiotics
until the last decade or two was achieved through observing and testing substances used by other
organisms to repel/kill bacteria (165). Newer antibiotic drugs rely on disrupting specific bacterial
pathways to maximize efficacy and minimize side effects (166). With each new drug developed,
resistance grows faster and creates more demand for diverse or combinatorial therapies to treat
infections. Biofilms are one of the main pathways used by infections to survive antibiotic
treatments (158). If the development of antibiotic resistance could be slowed, then the
preventative task of eliminating diseases could replace the current priority of treating those
already infected. Biofilms are commonly associated with infection in the case of agriculture this
is not always the case (17, 18). Treatment of crop and dairy supplies are crucial to preventing
disease and food spoilage (12). As previously mentioned even the presence of nonpathogenic
biofilm forming bacteria within milk during pasteurization can have negative consequences.
However, there are cases where eradication of bacteria is not the only goal. In the case of the
radish and tomato crops discussed earlier the presence of some biofilm forming bacteria are
immensely beneficial (17, 18). So, whether trying to remove an infection or promote a symbiotic
relationship understanding to manipulate and control biofilms is critical. To do this an
understanding of biofilm synthesis is important but also as important is the factors that give those
biofilms strength. Understanding how cellulose biofilms are O-acetylated is crucial in this
understanding, which is why research into proteins like WssF must be undertaken.
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7. Integrative nature of this research
Determining the integrative nature of my research was not difficult. Studying the putative
acetyltransferase WssF forced me to diversify not only how I thought about microbiology but
also how I was going to approach my research. When I started like most people, I thought about
my research in terms of how it would affect healthcare and the treatment of patients with
pathogenic biofilm forming bacteria. From the very beginning the need to remove biofilms as a
means of building antibiotic resistance was clear. What I came to see was that my research
would affect other areas of society. As previously mentioned, biofilms are ubiquitous, in the case
of agriculture a greater understanding of biofilms could lead to increased crop yields from both
prevention of bacterial diseases but also promotion of beneficial microbial communities. As a
result of this my research impacts both the areas of food consumption and the world’s
economies. On an individual’s level there are added benefits, personal hygiene as previously
discussed is directly impacted through the contamination of contact lens cases. Whether large or
small in scope my research had greater possibilities than just helping those in need. While
working on my research I discovered that microbiology would not be the only field I had to
understand. Growing microbes and controlling their expression was only the beginning of my
work. In order to understand how my protein functions, I had to expand my focus into organic
and analytical chemistry not to mention biochemistry. Determining reaction kinetics and building
pH profiles was a learning experience. More over my research around structural characterization
moved my focus firmly into the areas of structural biology and crystallography. Creating
crystallization conditions and changing small condition variables was only some of the new
skills developed. It is not hard to see how my research is integrative when these are so many
connections to healthcare, agriculture, organic chemistry, analytical chemistry, structural biology

116

and, crystallography. Compounding these connections are all of the disciplines of physics and
mathematics required to develop the machines and apparatuses required to complete my
research. These are just some of the reasons my research like all of biology is highly integrative
in nature.
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Appendix A.
Achromobacter insuavis AXX-A contig00047, whole genome shotgun sequence
TCATTTCTTCTGCAGCGCCTTGACCTGCGGCAGGTCGCCCAATTGCTTGGCAATGGCGTCGCCCCAGGC
TTTGTAGCCGGTGTTGGTGTAGTGCTGGCCGTCGGTGGTGGGCCACTGGCCGGGCGTCGAGAACTGGG
TCGAATCGATGTACGCGCAAGGCGCCACGTTGCTGCCCAGGAAGGCCGACACCTGCTTGACCCGCGCG
AAATTCTTGTTGTACTTGCCGCCCTCGGTGCCCCAGCTGGGACCGATCCAGACGCAGGCCGTGCCGGT
GCCGGAGATGGCCTTGGTCAGCGCGGTCGTCTGCTGCCAGGCCCAGGTCTTGGGAAAGGACGGATTGG
TGTAGCCGGCCATGGTGTCGCCGAGCACGATCACCACCAGGTTGGGCTTCTTGGCCGCGATCAGGTCG
GTCACCGGCGTGGTGCTGGCGTCCTTGCCCTTGAGCACGATCTGGCCGCCGTTCAGGCGCTCGGCGCC
GCCGCAGGTGCTGGGCGTGGCCTTGAGCCAGTCGCCGGCATTGCTGCCGCACACGCCGATGGTCTGCA
CCACCGCGCCCTGCTTGACCAGGTCGTCCTGCAGGGTCGTGATCAGGTAGCCCGGCGCGGCCAGATGG
CTGTCGCCGATCAGCAGGATGCTCATTCCGGCAAAAAGAGAGGTCAGCAT
Achromobacter insuavis AXX-A
MLTSLFAGMSILLIGDSHLAAPGYLITTLQDDLVKQGAVVQTIGVCGSNAGDWLKATPSTCGGAERLNGG
QIVLKGKDASTTPVTDLIAAKKPNLVVIVLGDTMAGYTNPSFPKTWAWQQTTALTKAISGTGTACVWIGPS
WGTEGGKYNKNFARVKQVSAFLGSNVAPCAYIDSTQFSTPGQWPTTDGQHYTNTGYKAWGDAIAKQLG
DLPQVKALQKK
Construct 1 (ordered from Genscript) – pET24-CtermHis
MLTSLFAGMSILLIGDSHLAAPGYLITTLQDDLVKQGAVVQTIGVCGSNAGDWLKATPSTCGGAERLNGG
QIVLKGKDASTTPVTDLIAAKKPNLVVIVLGDTMAGYTNPSFPKTWAWQQTTALTKAISGTGTACVWIGPS
WGTEGGKYNKNFARVKQVSAFLGSNVAPCAYIDSTQFSTPGQWPTTDGQHYTNTGYKAWGDAIAKQLG
DLPQVKALQKKlehhhhhh
Pseudomonas fluorescens SBW25
ATGCCTGTTTCTGCGATTGCCGGCCTAACCATGCTGGTATTGGGCGAAAGTCATATGAGCTTTCCCGAT
TCGTTGCTCAACCCGCTGCAAGACAACCTCACCAAGCAAGGCGCGGTGGTTCACTCCATCGGTGCGTG
CGGTGCCGGTGCGGCGGATTGGGTTGTGCCGAAAAAAGTCGAATGCGGCGGCGAACGCACGCCCACC
GGCAAGGCCGTGATCTATGGCAAAAACGCCATGAGCACCACGCCGATCCAGGAGCTGATCGCCAAAG
ACAAACCCGACGTGGTCGTGTTGATCATCGGCGACACCATGGGCTCCTACACCAACCCGGTGTTCCCT
AAAGCCTGGGCCTGGAAAAGCGTGACCTCGCTGACCAAAGCCATCACCGACACCGGCACCAAGTGCG
TGTGGGTCGGCCCGCCATGGGGCAAGGTCGGTTCGCAGTACAAGAAAGACGACACCCGCACCAAGCT
GATGTCGTCGTTCCTCGCCAGTAACGTGGCGCCGTGCACCTACATCGACTCGCTGACGTTCTCGAAGCC
AGGCGAGTGGATCACCACCGACGGCCAGCACTTCACCATCGACGGCTACCAGAAGTGGGCCAAGGCC
ATCGGTACAGCCTTGGGTGACCTGCCGCCATCGGCCTACGGTAAAGGAAACAAATAA
Pseudomonas fluorescens SBW25
MPVSAIAGLTMLVLGESHMSFPDSLLNPLQDNLTKQGAVVHSIGACGAGAADWVVPKKVECGGERTPTG
KAVIYGKNAMSTTPIQELIAKDKPDVVVLIIGDTMGSYTNPVFPKAWAWKSVTSLTKAITDTGTKCVWVGP
PWGKVGSQYKKDDTRTKLMSSFLASNVAPCTYIDSLTFSKPGEWITTDGQHFTIDGYQKWAKAIGTALGD
LPPSAYGKGNK
Construct 2 (ordered from Genscript) – pET24-CtermHis
MPVSAIAGLTMLVLGESHMSFPDSLLNPLQDNLTKQGAVVHSIGACGAGAADWVVPKKVECGGERTPTG
KAVIYGKNAMSTTPIQELIAKDKPDVVVLIIGDTMGSYTNPVFPKAWAWKSVTSLTKAITDTGTKCVWVGP
PWGKVGSQYKKDDTRTKLMSSFLASNVAPCTYIDSLTFSKPGEWITTDGQHFTIDGYQKWAKAIGTALGD
LPPSAYGKGNKlehhhhhh
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Appendix B.
To help iterate the function of these plates the following figures were created in excel to
visualize the layout of a standard 96 well microtiter plate. Each row of the plates contains a letter
designation while the columns are designated by a column number. These prelabelled plates
would allow for effective planning and efficient execution of the required assays.

A
B
C
D
E
F
G
H

1
A1
B1
C1
D1
E1
F1
G1
H1

2
3
4
5
6
7
8
9
10
A2
A3
A4
A5
A6
A7
A8
A9
A10
B2
B3
B4
B5
B6
B7
B8
B9
B10
C2
C3
C4
C5
C6
C7
C8
C9
C10
D2
D3
D4
D5
D6
D7
D8
D9
D10
E2
E3
E4
E5
E6
E7
E8
E9
E10
F2
F3
F4
F5
F6
F7
F8
F9
F10
G2
G3
G4
G5
G6
G7
G8
G9
G10
H2
H3
H4
H5
H6
H7
H8
H9
H10
Figure B.1 Example layout of an Assay Plate. Each well contains up to 300µL of liquid. Each plate
containing 96 wells. Made from black plastics for Fluourescence spectrometry or clear plastics for
colourimetric analysis.

A
B
C
D
E
F
G
H

1
Blank
Blank
Blank
Blank
1.13µL
1.13µL
1.13µL
1.13µL

2
Blank
Blank
Blank
Blank
1.13µL
1.13µL
1.13µL
1.13µL

3
Blank
Blank
Blank
Blank
1.88µL
1.88µL
1.88µL
1.88µL

4
Blank
Blank
Blank
Blank
1.88µL
1.88µL
1.88µL
1.88µL

5
Blank
Blank
Blank
Blank
1.81µL
1.81µL
1.81µL
1.81µL

6
Blank
Blank
Blank
Blank
1.81µL
1.81µL
1.81µL
1.81µL

7
Blank
Blank
Blank
Blank
3.75µL
3.75µL
3.75µL
3.75µL

8
Blank
Blank
Blank
Blank
3.75µL
3.75µL
3.75µL
3.75µL

9
Blank
Blank
Blank
Blank
5.63µL
5.63µL
5.63µL
5.63µL

11
A11
B11
C11
D11
E11
F11
G11
H11

10
Blank
Blank
Blank
Blank
5.63µL
5.63µL
5.63µL
5.63µL

Protein Concentration
0µM
0.3µM
0.5µM 0.75µM 1µM
1.5µM
Figure B.2 WssF Esterase Activity Assay Layout. Blank wells represent negative control conditions
(150µL of 100mM Sodium Phosphate pH 7, 15µL of 80mM 4-MUB Ac dissolved in DMSO, 135µL of
Millipore filtered H20). Samples are labelled with the volume of WssF protein added from a stock
(2mg/mL). Sample wells replace a volume of H2O with an equal volume of protein labelled on each well.
Colour is used to denote the final well concentration of the protein WssF.

12
A12
B12
C12
D12
E12
F12
G12
H12
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1
2
3
4
5
6
7
8
A Blank
Blank
Blank
Blank
WssF
WssF
WssF
WssF
B Blank
Blank
Blank
Blank
WssF
WssF
WssF
WssF
C Blank
Blank
Blank
Blank
WssF
WssF
WssF
WssF
D Blank
Blank
Blank
Blank
WssF
WssF
WssF
WssF
E Blank
Blank
Blank
Blank
WssF
WssF
WssF
WssF
Figure B.3 Zʹ 4-MUB-Ac Fluorescence assay Layout. Blank wells represent negative control
conditions (45µL of 50mM Sodium Phosphate pH 7, 0.5mM 4-MUB Ac and, 5 % (v/v) DMSO). Sample
wells contained constant concentrations of protein across the plate. Multiple assays were conducted with
various concentrations of protein (0.3µM, 0.5µM, 1µM).

A
B
C
D
E
F
G
H

1
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

2
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

3
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

4
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

5
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

6
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

7
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

pNP Ac Concentration
0.25mM 0.5mM
1mM
2mM
4mM
6mM
8mM
Figure B.4 Substrate Kinetic Assay Layout. Blank wells represent negative control conditions (75µL of
100mM Sodium Phosphate, 7.5µL of pNP Ac, 67.5µL of Millipore H2O). The concentration of pNP Ac
stock solutions vary depending upon desired final well concentration. Sample wells contain 7.5µL of
protein from a 1mg/ml stock resulting in a final well concentration of 2µM. Added protein volume
replaces an equal volume of H2O within the sample wells.
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A
B
C
D
E
F
G
H

1
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

Buffer
pH

A
B
C
D
E
F
G
H

1
Blank
Blank
Blank
Blank
Blank
Blank
Blank
Blank

2
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

3
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

4
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

5
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

6
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

7
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

8
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

9
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

10
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

11
Blank
Blank
Blank
Blank
7.5µL
7.5µL
7.5µL
7.5µL

Mes
Mes
Mes
Phosphate
Phosphate
Phosphate
Tris
Tris
Tris
Tris
5.5
6
6.5
6.5
7
7.5
7.5
8
8.5
9
Figure B.5 pH Profile Assay Layout. Blank wells represent negative control conditions (75µL of
100mM Sodium Phosphate, 7.5µL of 80mM pNP Ac, 67.5µL of Millipore H2O). Utilized Buffers: Mes
from pH 5.5-6.5, Sodium Phosphate from pH 6.5-7.5 and, Tris HCl from pH 7.5-9.25. Final well
concentrations were 4µM protein and 6mM 4-Nitrophenyl acetate. Added protein volume replaces an
equal volume of H2O within the sample wells.

2
Blank
Blank
Blank
Blank
Blank
Blank
Blank
Blank

Inhibitor (5mM)

3
Blank
Blank
Blank
Blank
Blank
Blank
Blank
Blank

4
Blank
Blank
Blank
Blank
Blank
Blank
Blank
Blank

5
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF

EDTA

MSF

PMSF

6
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF

7
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF

8
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF
AiWssF

9
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF

10
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF

11
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF

None

Figure B.6 Inhibitor Profile Assay Layout. Blank wells represent negative control conditions (75µL of
100mM Sodium Phosphate, 7.5µL of 80mM pNP Ac, 67.5µL of Millipore H2O). Final well
concentrations were 4µM protein and 5mM 4-Nitrophenyl acetate.

Tris
9.25

12
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF
PfWssF

135

15mg/ml A
17mg/ml B
13mg/ml C
29.5mg/ml D
25mg/ml E
29.5mg/ml F
25mg/ml G
H

1
20%
20%
20%
20%
20%
15%
15%
25%

2
20%
20%
20%
20%
20%
15%
15%
25%

3
23%
23%
23%
23%
23%
18%
18%
25%

4
23%
23%
23%
23%
23%
18%
18%
25%

5
25%
25%
25%
25%
25%
20%
20%
25%

6
25%
25%
25%
25%
25%
20%
20%
25%

7
27%
27%
27%
27%
27%
22%
22%
25%

8
27%
27%
27%
27%
27%
22%
22%
25%

9
30%
30%
30%
30%
30%
25%
25%
20%

10
11
12
30% N/A N/A
30% N/A N/A
30% N/A N/A
30% N/A N/A
30% N/A N/A
25% N/A N/A
25% N/A N/A
20% 20% 20%

% (w/v) PEG 3350
0.1 M HEPES:NaOH pH 7.5, % (w/v) PEG
3350
0.1 M Bis-Tris:HCl pH 6.5, % (w/v) PEG
MME 5000
Figure B.7 Protein Concentration Expansion Plate Layout. Example of expansion plates made from
successful conditions. Shaded coded based on well condition. H1-H4, 15mg/mL; H5-H12, 25mg/mL.
Percentages represent concentration of PEG used for each condition.

A
B
C
D
E
F
G
H

1
5.6
5.6
5.6
5.6
5.6
5.6
5.6
5.6

PEG 3350
Concentration

2
6.2
6.2
6.2
6.2
6.2
6.2
6.2
6.2

19%

3
6.4
6.4
6.4
6.4
6.4
6.4
6.4
6.4

4
6.8
6.8
6.8
6.8
6.8
6.8
6.8
6.8

21%

5
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7.4

23%

6
7.4
7.4
7.4
7.4
7.4
7.4
7.4
7.4

25%

7
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

8
7.6
7.6
7.6
7.6
7.6
7.6
7.6
7.6

25%

9
7.8
7.8
7.8
7.8
7.8
7.8
7.8
7.8

27%

10
8
8
8
8
8
8
8
8

29%

11
8.2
8.2
8.2
8.2
8.2
8.2
8.2
8.2

12
8.4
8.4
8.4
8.4
8.4
8.4
8.4
8.4

31%

Figure B.8 pH and PEG Expansion Plate Layout. Example of expansion plate based on successful well
condition 15 mg/mL protein (Top) TOP96-E2: 25 % (w/v) PEG 3350, varied pH (5.6-8.4) and PEG
concentrations (19-31 % (w/v)).
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Table B.1 Molar Absorptivity Values. Molar absorptivity values used to calculate esterase activity of
pNP Ac at various pH levels in Figure 4.11.

pH (Buffer)

Molar
Absorptivity
(mmol-1 cm-1)

5.5 (MES)
6 (MES)
6.5 (MES)
6.5 (NaP)
7 (NaP)
7.5 (NaP)
7.5 (Tris-HCl)
8 (Tris-HCl)
8.5 (Tris-HCl)
9 (Tris-HCl)
9.25 (Tris-HCl)

3804
12004
28288
30100
57282.66
90276
83756
96040
103049.33
94561.33
108752

9.5 (Tris-HCl)

104952

TLC Activated carbon column preperation protocol.
1. The column was charged with one column volume (3 mL) of acetonitrile (100 % (v/v)).
2. The column was washed with two column volumes (6 mL) of water.
Filtration protocol
1.
2.
3.
4.
5.

150 µL of reaction mixture (Esterase activity assay) was diluted to 1 mL with ddH2O.
Diluted sample was added to the column for 2 min.
The column was washed with two column volumes (6 mL) of ddH2O.
Bound cellulose was eluted with 0.5 mL of 50 % (v/v) acetonitrile
Any remaining cellulose was eluted with 0.5 mL 100 % (v/v) acetonitrile in a separate
sample

Column cleaning protocol
1. The column was washed twice with 2 mL of 50 % (v/v) Tetrahydrofuran or THF.
2. The column was washed with two column volumes (6 mL) of ddH2O.
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TLC protocol
1. Mobile phase was made and added to a glass tank, to a depth of 1 cm, 1 h before plates
were to be added to the tank, which allowed for vapour diffusion.
2. 20 cm x 20 cm aluminum backed silica gel plate was cut to appropriate size.
3. A pencil line was drawn 1 cm from bottom of plate with marks every 1 cm for loading,
outside marks were 1.5 cm from the edge of plate. Each mark was labeled with the
sample to be loaded in that location.
4. Sample was loaded into 10 µL glass capillary tubes followed by absorption on to the
plate. Each sample was absorbed onto their corresponding mark.
5. After each sample was loaded, the plate was left for 10 minutes to dry.
6. Steps 4 and 5 were repeated 5 times before the plate was added to the tank.
7. The plate was developed in the tank until the solvent front reached 1 cm from the top of
the plate
8. The plate was removed from tank and pencil line was drawn along the upper solvent front
before being left to dry for 20 minutes.
9. The plate was sprayed with Naphthol stain (contained within a fume hood) until slight
discolouration appeared without completely dampening the plate.
10. The plate was placed on a hot plate (Contained within fume hood) until the stained bands
appeared.
*After addition of Naphthol stain all materials should remain in fume hood unless
required.
** Mobile phase (8:3:4): 53.33 mL ethyl acetate, 20 mL ddH2O, 26.67 mL Methanol.
*** Naphthol Stain (25:3:2): 208.33 mL Methanol, 25 mL H2SO4, 16.67 mL ddH2O. (H2SO4
added slowly and last to avoid boiling the solution)

